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 High arterial tortuosity, or twistedness, is a sign of many vascular diseases. Some 
ocular diseases are clinically diagnosed in part by assessment of increased tortuosity of 
ocular blood vessels. Increased arterial tortuosity is seen in other vascular diseases but is 
not commonly used for clinical diagnosis. This study develops the use of existing 
magnetic resonance angiography (MRA) image data to study arterial tortuosity in a range 
of arteries of hypertensive and intracranial aneurysm patients.  
 The accuracy of several centerline extraction algorithms based on Dijkstra’s 
algorithm was measured in numeric phantoms. The stability of the algorithms was 
measured in brain arteries. A centerline extraction algorithm was selected based on its 
accuracy. A centerline tortuosity metric was developed using a curve of tortuosity scores. 
This tortuosity metric was tested on phantoms and compared to observer-based tortuosity 
rankings on a test data set. The tortuosity metric was then used to measure and compare 
with negative controls the tortuosity of brain arteries from intracranial aneurysm and 
hypertension patients. 
 A Dijkstra based centerline extraction algorithm employing a distance-from-edge 
weighted center of mass (DFE-COM) cost function of the segmented arteries was 
selected based on generating 15/16 anatomically correct centerlines in a looping artery 




compared to 15/16 for the center of mass (COM) cost function and 7/16 for the inverse 
modified distance from edge cost function. The DFE-COM cost function had a lower root 
mean square error in a lopsided phantom (0.413) than the COM cost function (0.879). 
The tortuosity metric successfully ordered electronic phantoms of arteries by tortuosity. 
The tortuosity metric detected an increase in arterial tortuosity in hypertensive patients in 
13/13 (10/13 significant at α = 0.05). The metric detected increased tortuosity in a subset 
of the aneurysm patients with Loeys-Dietz syndrome (LDS) in 7/7 (three significant at α 
= 0.001).  
 The tortuosity measurement combination of the centerline algorithm and the 
distance factor metric tortuosity curve was able to detect increases in arterial tortuosity in 
hypertensives and LDS patients. Therefore the methods validated here can be used to 
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 Many vascular diseases affect arteries altering lumen diameter, vessel wall 
thickness and shape. One method used to quantify the shape of arteries is to measure their 
tortuosity or twistedness. Diseased arteries may have increased arterial tortuosity 
compared to healthy arteries. This research developed software for quantitatively 
measuring and comparing tortuosities of arteries from disease and negative control 
populations to determine which diseases are associated with arterial tortuosity.  
Arterial tortuosity 
Clinical diagnosis by arterial tortuosity 
 Some vascular diseases are known to correlate with increased arterial tortuosity. 
Arterial tortuosity is included in diagnosis before venous tortuosity because arteries are 
under higher pressure than veins and will be affected by pressure more. Arteries were 
found in vitro to exhibit increased tortuosity with increasing pressure [1]. Arteries are 
afflicted by aneurysms more often than veins. Autopsy studies have shown intracranial 
aneurysm rates of 0.2 to 9.9 (mean 5%) percent in the general population [2], whereas a 





of 2000 patients (1.5%) and this hospital population may be an overestimate of the 
frequency in the general population [3]. Ophthalmologists and other clinicians use high 
tortuosity of the retinal blood vessels seen in fundus photographs of the dilated pupil to 
diagnose retinal diseases such as retinopathy of prematurity [4]. High tortuosity is also 
used to diagnose retinitis pigmentosa and diabetic retinopathy, and low tortuosity is used 
to identify retinal vasculitis [5]. Rapidly growing cancer tumors recruit new highly 
tortuous arteries by angiogenesis [6]. Genetic syndromes such as arterial tortuosity 
syndrome [7] and Loeys-Dietz syndrome (LDS) [8, 9] are known to increase arterial 
tortuosity.  
 Arterial tortuosity is one of the differentiating characteristics between the rare and 
newly described LDS and the more common (occurring in 2-3 per 10000 individuals) and 
better known Marfan syndrome (MFS) [10] [11-15]. In addition patients with LDS have 
also been misdiagnosed with Ehlers-Danlos syndrome type IV, which is caused by a 
mutation in the COL3A1 gene and is not known for high arterial tortuosity [7]. In a study 
of 25 LDS patients all 25 were visually assessed as having high arterial tortuosity [16]. 
LDS causes aneurysms in a wider anatomical area than MFS requiring imaging over a 
wider range of anatomy, making the correct LDS diagnosis important [17]. Arterial 
tortuosity may be a distinguishing characteristic between LDS and related diseases.  
 Distinguishing between MFS and LDS is important. LDS is a highly aggressive 
disease. Twenty per cent of LDS patients have aneurysms of the head or neck [9]. Mean 
age at death for LDS type I (TGFBR1 mutation) was 22.6 versus 31.8 for type II 





differences [9]. MFS and LDS have many overlapping clinical characteristics making 
misdiagnosis possible [14]. MFS patients are only followed with aortic arch imaging 
whereas LDS patients need more comprehensive imaging to detect aneurysms in other 
parts of the body [12, 17]. MFS patients get aortic arch aneurysms that can rupture. MFS 
patients show no abnormal risk of nonaortic arch aneurysms while 92% of LDS patients 
develop other aneurysms [8]. 
 Currently the clinical diagnosis of retinal diseases and LDS includes visual 
qualitative assessment of blood vessel tortuosity. Validation of quantitative tortuosity 
measurements is needed to develop quantitative tortuosity measurement for clinical 
diagnosis.  
Medical implications of tortuosity 
 Tortuosity of blood vessels has medical implications. Highly tortuous arterioles 
may require high blood pressure (hypertension) to push blood cells through small twisted 
arterioles [18]. Highly twisted arteries have physically prevented stenting [19]. High 
arterial tortuosity may also be a sign of weakened arterial walls caused by defects in 
proteins such as elastin [1]. The force of blood moving parallel with the blood vessels 
may stretch them increasing length causing tortuosity [1]. Blood pressure forces 
perpendicular to the blood vessels may stretch the walls out resulting in aneurysms [1]. 







 Vascular diseases cause different types of tortuosity. Tortuosity has been 
characterized in three types [20]. In type I tortuosity arteries exhibit broad meandering 
curves. High type II tortuosity arteries have dense nests of curved and erratically twisting 
vessels of a variety of lengths. The final type III tortuosity arteries have high frequency 
low amplitude coils or sinusoidal curves [20]. Type I tortuosity broadly affects arteries’ 
complete structure and is likely caused by underlying systemic disease. Type II tortuosity 
has been associated with arteriovenous malformations and III tortuosity has been 
associated with tumor angiogenesis [20]. 
Tortuosity measures 
 Several methods to measure arterial tortuosity have been developed. Most 
tortuosity measurements are made on centerlines through the middle of the arteries. 
Centerlines simplify the arteries to a single line passing through the middle of the artery 
making measurement of length possible. The distance factor metric (DFM) measures the 
ratio of the length L along arterial centerlines divided by the straight distance d between 
two end-points [4, 20-25]. The inflection count metric (ICM) multiplies the number of 
direction changes by the DFM to factor in the number of changes in direction [20, 26]. 
The sum of angles metric (SOAM) measures a sum of angles along the centerline [20, 
26]. The tortuosity measure used on arterioles in microscopy slides measures the ratio of 
the length of the largest twist in the blood vessel to the largest diameter of the blood 





second derivative of the centerline that is sensitive to abrupt changes along the centerline 
[22, 28]. The different tortuosity measures vary in which types of arterial tortuosity they 
detect. 
Relationship between tortuosity types and measures 
 Different existing measures of tortuosity work better for different types of 
tortuosity. The most commonly used measure has been the DFM partly due to its 
simplicity of implementation. The DFM performs well detecting high type I tortuosity 
arteries but not well detecting high type II and type III [20]. The SOAM performed well 
on type III but not on type I or II. The inflection count metric (ICM) [20] worked well 
detecting type I and type II tortuosity. The SOAM and ICM measurements were 
developed to measure small areas of local tortuosity seen in tumor angiogenesis [20, 28]. 
Quantitatively measured vascular diseases 
 Previous research has correlated several vascular diseases with quantitative 
tortuosity metrics. DFM based methods detected increased arterial tortuosity in retinal 
blood vessels with retinopathy of prematurity [1]. Measurements based on the integral of 
second derivative of the centerline measured increases in retinal blood vessel tortuosity 
with retinitis pigmentosa and diabetic retinopathy and decreased tortuosity with vasculitis 
compared to normal controls [2]. The ratio of the diameter of the largest loop to largest 





vessels from autopsy in hypertensive patients [27]. The SOAM measured an increase in 
arterial tortuosity with aging in magnetic resonance angiography (MRA) images while 
the ICM measurement did not in the same data set [29]. The ICM found a decrease in 
tortuosity of the middle cerebral arteries from MRA images with increased 
cardiovascular exercise which was not seen with the SOAM measurement [30]. However 
many diseases, even some known to increase arterial tortuosity visually, have not been 
quantitatively investigated and clinical use of quantitative measurement is not widespread 
and only appears to be used consistently with retinal arteries. 
Arterial tortuosity measurement method 
 This study is concerned with the relationship between blood vessel tortuosity and 
vascular disease. The study started with the DFM tortuosity measure due to its ability to 
detect type I tortuosity and simplicity of implementation. Tortuosity measure by 
curvature of the centerline was also implemented by numeric integration of the second 
derivative along the centerline. The curvature required specification of many 
implementation parameters that change the measures. The DFM tortuosity measure was 
free of implementation parameters. The study started with the DFM tortuosity measure to 
detect arterial tortuosity. When and if the DFM tortuosity measure proved ineffective 
modifications were made to the measure. The tortuosity measurement software developed 





Imaging blood vessels 
 Blood vessels can be imaged for tortuosity measurement by several different 
modalities. Retinal blood vessels are routinely imaged in two dimensions in fundus 
photography by ophthalmologists [21, 31]. Small arterioles are imaged in two-
dimensional histological photomicrographs but only in autopsies [27, 32]. Digital 
subtraction angiography (DSA) with contrast agents creates high resolution two-
dimensional projection images that can display small arteries and veins [33]. CTA with 
contrast agents images both arteries and veins in three dimensions. And MRA can image 
both arteries and veins or arteries only in three dimensions. MRA’s ability to isolate 
arteries (Figure 1.1 A) from veins simplifies measurement of arteries [34] since veins can 
obscure the arteries (Figure 1.1 B). 
Risks of ionizing radiation in imaging 
 DSA and CTA expose the patients to ionizing radiation and contrast agents. 
Ionizing radiation potentially increases the risk of cancer in a linear no lower threshold 
manner [35]. No lower threshold means that when large numbers of patients are exposed 
to even small radiation doses, cancers are generated by the imaging [36-38]. Contrast 
agents used in DSA and CTA can have side effects. Patients can be allergic to contrast 





Nuclear magnetic resonance imaging safety 
 Nuclear magnetic resonance (NMR) is the basis of magnetic resonance imaging 
(MRI) and MRA which can image blood vessels without ionizing radiation or contrast. 
MRI scanners typically measure the collective signal from the protons that are the nuclei 
of hydrogen atoms from water and lipids and other hydrocarbons in the body. Therefore 
the magnetic resonance (MR) signal comes from the subject themselves although MRI 
scanners emit nonionizing radiation waves to image subjects. Added ionizing radiation or 
contrast agents are not required. Contrast agents do exist that can be injected to increase 
image contrast between different tissues, but are not always necessary. Thus MRI has no 
known long term side effects [39, 41].  
Nuclear magnetic resonance basics 
 The following provides a classical physics description of NMR. The NMR signal 
employed in MRI typically comes from the hydrogen proton nuclei. Imaging based on the 
nuclei of other atoms exists but is less common. The protons have nuclear magnetic 
moments µ that in the absence of an applied magnetic field are oriented in random 
directions and sum to produce zero net bulk magnetization M = Σµall = 0. In the presence 
of a magnetic field B, any given magnetic moment µ will precess about the direction of 
the applied field B with a frequency known as the Larmor frequency: ω = γB
.
 The type of 
atom determines the gyromagnetic ratio γ, which is 42.58 MHz/Tesla (T) for hydrogen. 
The magnetic moments µ will not produce a measurable signal until they come into 





magnetic field vector B0, after a short time through a process known as relaxation, the 
magnetic moments have a tendency to align parallel with the field to sum to produce a net 
longitudinal bulk magnetization M = Σµall > 0. The bulk magnetization M is then 
manipulated to produce the measured NMR signal that is used to reconstruct the 
anatomical image. 
 An additional electromagnetic radio frequency (RF) pulse B1 applied 
perpendicular to the B0 field at the resonance frequency, ω, tips the bulk magnetization M 
out of alignment with B0. At this point, the bulk magnetization vector M has a 
longitudinal component Mz and transverse component Mxy with a tip angle α between the 
vector of M and the vector of B0 (Figure 1.2). Like the underlying magnetic moments µ, 
M precesses or wobbles around the B0 vector axis like a spinning top or dreidle in a cone 
pattern with a transverse Mxy bulk magnetization component perpendicular to the B0 
field. The Mxy component of the magnetization forms the basis of the detected NMR 
signal. After tipping, through a process of relaxation the bulk magnetization returns to 
alignment with B0 recovering the Mz component while reducing the Mxy component.  
 The recovery of Mz and Mxy to equilibrium is known as relaxation. The speed of 
relaxation is tissue dependent. Two forms of relaxation exist governing the recovery of 
Mz and the destruction of Mxy. Each specific tissue has a longitudinal T1, related to the 
recovery of Mz, and transverse T2, related to the loss of Mxy. Tissue specific differences in 
T1 and T2 and the proton density (PD) (increased proton density increases signal) are used 






MRI hardware components 
 An MRI scanner has three main hardware components: a main magnet, a 
magnetic field gradient system, and a radio frequency (RF) system [39]. The main 
magnet creates a static homogeneous magnetic field B0. The subject is placed in the 
magnetic field and the bulk magnetization M of the subject aligns with the B0 field. The 
gradient system alters the local magnetic environment to allow localization of the bulk 
magnetization. The RF system tips the magnetization away from B0 and receives signals 
produced by the precessing transverse bulk magnetization Mxy [39, 41]. 
Main magnet 
 The main magnet is typically a cooled superconducting magnet that creates the 
strong nearly uniform static field B0. Good image quality requires homogeneity of the 
magnetic field B0, which the main magnet is usually not capable of alone. Shim coils add 
magnetic field to even out the B0 field of the main magnet. The magnets are contained in 
a long hollow cylindrical shaped case with a hollow bore. The subject lies on a movable 
table that slides into the hollow bore for imaging. 
 MRI scanners now typically come in 1.5 T, 3.0 T and 7.0 T field strengths. A 
Tesla (T) is the Système international d'unités (SI) unit of magnetic field strength. For 
comparison the Earth’s magnetic field at the equator is 31 µT and a refrigerator magnet is 
around 5 mT. MRI scanners at 1.5 T and 3.0 T are FDA approved and are commonly 
used in clinical imaging. Scanners at 7.0 T are not FDA approved for clinical use but can 





Higher field strengths have increased signal to noise ratios which can be employed to 
acquire images at higher resolutions making imaging of smaller arteries possible [42-44].  
Gradient fields 
 A gradient in the main B0 field is needed for signal localization to create the three-
dimensional image. Without the gradient the scanner could detect tissue signals but 
would not know where the tissues are located and would not be able to reconstruct the 
image. Gradients Gx, Gy and Gz are created by coil systems positioned around the bore 
and each modify the z-component of the main field along the spatial x, y and z directions, 
respectively. The field due to the gradients Bg = xGx + yGy +zGz changes the magnetic 
field B = B0 + Bg making the resonance frequency ω = γ(B0 + xGx + yGy + zGz) a 
function of position. In practice the gradients are seldom all turned on at the same time 
but are turned on and off as part of the image acquisition process. 
Radio frequency system 
 The radio frequency (RF) system has transmitter and receiver coils. Some systems 
use a combined transceiver coil. The transmitter applies uniform B1 magnetic fields 
perpendicular to B0 at specific resonance frequency to the subject. MRI scanners come 
with whole body coils inside the case of the main magnet and specially designed surface 
coils which may be placed close to anatomy of interest [39]. Surface coils placed on or 





small structures such as narrow diameter arteries [45]. After the transmitted B1 RF ends, 
the receiver coils detect the precession of the transverse bulk magnetization Mxy.  
Generation of MRI image 
 The MR image is acquired by sampling NMR signals from the transverse bulk 
magnetization Mxy of the subject. The RF system and gradients are used to manipulate 
and sample signals of the bulk magnetization M throughout the spatial frequency or 
Fourier domain also known as k-space described below. Successive manipulations 
measure sample frequencies throughout k-space. When k-space has been completely 
sampled the anatomical spatial domain is recovered by an inverse Fourier transform [39, 
41].  
 First, the gradient coils are used to select a slab for excitation. A Gz gradient alters 
the resonance frequency linearly of the protons along the Z axis parallel to B0 according 
to ω(z) = γ(B0 + zGz). The transmission RF coils apply B1 perpendicular to B0 in a pulse 
at a narrow band width of resonance frequencies exciting a slab perpendicular to B0 with 
known Z location. The Gz gradient and B1 RF pulse are ended. Localization of the signal 
along the Y and X directions is imposed with phase and frequency encoding by gradients 
Gy and Gx. The Gy gradient phase encodes the signal by applying gradient in B parallel to 
B0 but varying along Y for a time-duration Tpe changing the resonance frequencies 
linearly along the Y axis according to ω(y) = γ(B0 + yGy). After the Gy gradient ends the 
resonance frequencies all return to the previous resonance frequency ω but the relative 





signal according to ϕ(y) = -γ y GyTpe. The Gx gradient turns on to frequency encode the 
signal by changing the resonance frequencies linearly along the X axis according to ω(x) 
= γ(B0 +xGx). The gradient encoding along the X axis and phase encoding along the Y 
axis of signal frequencies form the frequency domain of the image known as k-space. 
The k-space frequency signals of the image are sampled with the MRI scanner by 
manipulating the gradients, RF-pulses to guide the scanner through k-space. The 
frequency signals are converted with an analog to digital converter (ADC) for digital 
recording. When sufficient frequencies of k-space are sampled and recorded the 
frequency signals are inverse Fourier transformed in two dimensions or three dimensions 
into image space creating the image.  
 The image acquisition can be in two dimensions or three dimensions. In the two-
dimensional acquisition the B1 RF pulse excites a narrow slab determining the Z position. 
In three dimensional imaging the B1 RF pulse excites a wide slab and then a second Gz 
gradient is used to phase the spins to encode location on the Z axis. The choice of two- or 
three-dimensional acquisition depends on the imaging application.  
 Repeated Gy phase encoding gradients at different magnitude Gy and/or duration 
Tpe selectively encode the k-Y axis rows of k-space. The Gx gradient frequency encodes 
the k-X axis columns of k-space and the ADC receiver samples the magnitudes of 
frequencies at time intervals while the frequency encoding Gx gradient is turned on. The 
gradients are manipulated to sample k-space in patterns to collect data from sufficient 





 The combination of RF pulses, gradients and receiver listening periods are 
collectively known as a pulse sequence. The pulse sequence specifies the timing, 
magnitude, duration and order of RF pulses, gradients and signal sampling (turning on 
the receiver). The timing between repetitions of the B1 RF pulse is repetition time TR and 
the time between the B1 RF pulse and the peak signal of the echo is echo time TE. Pulse 
sequences use differences in longitudinal T1 relaxation times, transverse T2 relaxation 
times and proton density of the tissues to create contrast that make tissues borders in the 
image visible and selectively highlight or suppress tissues types.  
Time-of-flight magnetic resonance angiography 
 Time-of-flight (TOF) magnetic resonance angiography (MRA) pulse sequences 
have the ability to distinguish moving blood from immobile background tissues. MRA 
even takes advantage of arterial blood moving faster than venous blood to highlight 
arterial blood while suppressing venous blood [46]. MRA uses thick slab B1 RF 
excitation pulses and three-dimensional data acquisition. MRA pulse sequences use 
repeated B1 RF slab selection excitation pulses and gradient echoes with small tip angles 
spaced close together in time with short TR and short TE that saturates the excited tissues. 
The saturated background tissues are not able to recover their longitudinal magnetization 
[47, 48]. The blood within the excited volume is continuously replaced by fresh blood 
flowing into the volume. As a result, the blood does not experience the signal saturation 
and appears as bright tissue in the image. [40, 46, 49]. By keeping the TR times very short 





fast moving arterial blood brightest [47]. Even the arterial walls will be dimmer than the 
moving blood [47]. Diseased arteries with low blood flow may also appear dim or not be 
visible at all [45]. Thus MRA is showing physiology and not just anatomy [49]. TOF-
MRA images are not free of background tissues due to signal recovery by short T1 tissues 
[48]. These background tissues may have intensities as high as the arterial blood [47] 
requiring extra image postprocessing steps to segment the arterial blood from these 
background tissues. The amplification of the flowing blood by the pulse sequence allows 
this procedure to be done without contrast, thereby increasing patient safety [34].  
Filling a gap in research 
 Quantitative arterial tortuosity measurements are rarely used clinically. More 
research is needed to validate quantitative arterial tortuosity measurement for clinical use. 
Arterial tortuosity of only a limited numbers of vascular diseases has been studied. 
Arterial tortuosity due to tumors is a local phenomenon but it is not known if systemic 
vascular diseases such as hypertension correlate with increased arterial tortuosity in all or 
only limited arteries. Tortuosity measurements are needed for more arteries in more 
vascular diseased populations to build evidence for clinical use of quantitative tortuosity 
measurements. 
 One major obstacle to studying arterial tortuosity is the cost of imaging new 
subjects and corresponding negative controls. MRA images already exist for many 





tortuosity in these existing images opens up a low cost and quick method to study the 
effects of many vascular diseases. 
 There are many challenges to studying arterial tortuosity using existing MRA 
images. The existing images from clinical scans and previous research studies were often 
acquired with different scanners and parameters, covering different arteries or parts of 
arteries at different resolutions. Corresponding negative controls are not collected for 
clinical scans. The challenges of correlating arterial tortuosity with vascular diseases in 
existing MRA are studied in three experimental papers submitted for publication in peer 
reviewed journals and duplicated here in Chapters 2, 3 and 4. 
Tortuosity measurement and analysis system 
 The experiments to correlate arterial tortuosity with vascular diseases were 
conducted with an arterial tortuosity measurement and comparison system developed in 
the course of this research. The system included plugins to ImageJ [51], an image 
processing tool. The plugins handled image processing tasks such as filtering, 
segmenting, calculating the centerline and selecting arteries for tortuosity measurement. 
Arterial tortuosity measures were computed from centerline data compiled in the 
database and analyzed using the statistical environment, R [52]. The statistical analysis 
environment and relational database were also used to organize data by case and control 







 In Chapter 2 the first paper “Comparing Performance of Centerline Algorithms 
for Quantitative Assessment of Brain Vascular Anatomy” tackles the issues of generating 
centerlines for all arteries of interest. Centerlines are necessary for the tortuosity 
measurements. To measure tortuosity in a large range of different arteries, centerline 
algorithms must be able to consistently make centerlines that accurately represent the 
anatomy of the arteries. In this experiment different Dijkstra based centerline algorithms 
are compared for their ability to create accurate and stable centerlines in numeric 
phantoms of different shapes and in MRA brain images. One of the most challenging 
arteries to calculate centerlines for is the internal carotid artery (ICA) in the brain. 
Anatomically, the ICA has a looping structure where distant inferior (or upstream) and 
superior (or downstream) portions of the vessel are nearly adjacent. During segmentation 
of the ICA from the background, the adjacent portions of vessel are often erroneously 
connected, resulting in a shortcut or “kiss” which subsequently affects the centerline 
extraction. The study measures and selects a centerline algorithm that can draw 
centerlines around the difficult loop of the ICA without taking the kissing shortcut. 
 In Chapter 3 the paper “Validation of an Arterial Tortuosity Measure with 
Application to Hypertension” further refined the centerline algorithm and developed and 
tested a tortuosity measurement method. Tortuosity was measured by calculating DFM 
tortuosity curves rather than single DFM tortuosity measurements and tested the 
underlying DFM tortuosity measurement on numeric phantoms and on hypertensive and 





image data. The images in this study truncated arteries at different points making direct 
comparison at the same end-points impossible. The study uses DFM tortuosity curves to 
compare truncated arteries. The study also has image data for the same subjects acquired 
at different resolutions making it possible to measure the effect of resolution on the DFM 
tortuosity metric and develop a strategy to reduce the resolution effect. The study also 
compares negative controls collected with different methodologies. 
 Hypertension was an interesting vascular disease for arterial tortuosity 
measurement. Hypertension had been correlated with increased tortuosity of brain matter 
arterioles from autopsy photomicrographs [27]. Large arteries observed in vivo with 
MRA images of living subjects have not been correlated with increased tortuosity before 
this study. The study included a set of hypertension data acquired at 7.0 T which is rare. 
The 7.0 T data set contained images of large diameter arteries like the ICA down to the 
small diameter lenticulostriate arteries not seen at lower field strength. 
 In Chapter 4 the paper “Medical Record and Imaging Evaluation To Identify 
Arterial Tortuosity Phenotype in Populations At Risk For Intracranial Aneurysms” 
examines the relationship between arterial tortuosity and intracranial aneurysms. In a 
previous study on the mechanisms of arterial and aneurysmal tortuosity, the elastin 
protein of extracted arteries was degraded in vitro weakening the arterial walls causing 
increased arterial tortuosity and aneurysmal dilations [1]. There were no previous studies 
on patients with intracranial aneurysms. This study looked for increased arterial tortuosity 
in populations with familial intracranial aneurysms, unaffected members of high 
intracranial aneurysm risk pedigrees and in other patients with intracranial aneurysms. 
  
Figure 1.1.Arterial imaging modalitites.
(MIP) image of TOF-MRA image displays flowing arterial blood. (Right) Both 
veins and arteries appear in the computed tomography angiography (CTA) se
mented blood vessel image making arteries difficult to distinguish.
 







Figure 1.2. The bulk magnetization vector M precesses about the static magnetic 
field vector B0 at resonance frequency 
transverse component Mxy 
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 Attributes like length, diameter and tortuosity of tubular anatomical structures 
such as blood vessels seen in medical images can be measured from centerlines. This 
study develops methods for comparing the performance of centerline algorithms. Several 
centerline algorithms exist but there are challenges to calculating centerlines. The starting 
point of a vascular tree can affect calculated centerlines. Vessels can loop back touching 
or kissing themselves causing problems for centerline algorithms. This study develops 
methods for evaluating the accuracy and stability of centerline algorithms. 
 Images of human brain arteries were acquired with time of flight (TOF)–magnetic 
resonance angiography (MRA) and the arteries were segmented. Dijktra's shortest paths 
based centerline algorithms were developed with different cost functions. The cost 
functions were the inverse modified distance from edge (MDFEi) of the segmentation, the 
center of mass (COM) of the segmentation, the binary thinned (BT)-MDFEi and the BT-
COM. The algorithms generated centerlines trees of simulated numeric vasculature 
phantoms and of segmented brain arteries. The accuracy of the centerline algorithms 
were measured by the Root Mean Square Error from known centerlines of electronic 
phantoms. The stability of the centerlines was measured by starting the centerline tree 
from multiple points and measuring the differences between the centerline trees. The 





vasculature images. The visualization was used to assess algorithm performance on a 
kissing vessel in human brain arteries. 
 The BT-COM cost function centerline was the most stable in numeric phantoms 
and human brain arteries. The MDFEi based centerline was most accurate in the numeric 
phantoms. The COM based centerline handled the kissing artery in the human brain in 16 
out of 16 cases whereas the BT-COM was correct in 10 out of 16 and MDFEi was correct 
in 6 out 16. 
 The COM based centerline algorithm handled the kissing arteries of the brain 
images and will be used for quantitative assessment of vascular morphology in later 
studies. The highest stability did not correspond with the highest accuracy in numeric 
phantoms. The highest stability and accuracy in numeric phantoms also did not 
correspond to the best centerlines in subject data. The centerline visualization methods 
were critical for assessing centerlines in subject data. 
Key words: Centerline, MRA, stability, vascular. 
Introduction 
 Vascular diseases can be diagnosed and characterized by abnormalities in blood 
vessel morphology observed with three-dimensional medical imaging techniques such as 
magnetic resonance angiography (MRA). An example of this includes the correlation of 
the severity of hypertension with tortuosity or twistedness of arteries (Hiroki et al., 2002). 
Currently, nearly all medical evaluation of 3D images is performed qualitatively by 





radius, length and tortuosity (twistedness) measurements by computer software would 
make comparison of measurements across medical centers, tracking changes over time, 
and automated screening for vascular disease possible. Quantitative assessment of artery 
morphology can be made from centerlines of arteries (O’Flynn et al., 2007; Lesage et al., 
2009). Arterial centerlines have also been used to measure the tortuosity of blood vessels 
(Bullitt et al., 2003). Centerlines can be used to measure artery lengths and radius. 
Change of radius in arterial centerlines can potentially detect stenoses and aneurysms 
(Frangi et al., 1999; Kang et al., 2009; Lesage et al., 2009). Centerlines can be used for 
many tasks involving the quantitative analysis of blood vessels. 
 Stable and accurate centerline algorithms are needed to quantitatively measure 
and investigate the blood vessels and the effects of disease on blood vessels. Stability of 
the centerline is the ability of an algorithm to create the same centerline for the same 
image data with different input parameters, primarily the starting point of the centerline 
tree. Accuracy refers to how close a calculated centerline is to an ideal centerline for a 
numeric phantom. Centerline accuracy and stability measurement methods are needed to 
select the best algorithms for generating centerlines for a quantitative task. Accuracy and 
stability visualization methods are needed to know where centerlines are accurate or 
inaccurate, stable or unstable. Different studies will have different areas of interest; the 
researcher will want to know if the centerline is accurate and stable in the area of interest. 
For example intracranial aneurysms typically occur in the circle of Willis arteries, which 
experience higher blood pressure and pressure variations than the peripheral intracranial 





important that the circle of Willis arterial centerlines are stable whereas the stability of 
the peripheral arterial centerlines is less important to aneurysm assessment. 
 The purpose of this study is to develop methods for measuring and visualizing the 
accuracy and stability of centerline algorithms and select the best available algorithm for 
creating centerlines in central arteries of human brain MRA images. Arterial centerlines 
have the potential for developing diagnostic and descriptive measures of vascular 
diseases. The methods developed here may also be used to quantify tubular structures in 
any three-dimensional image.  
Materials and methods 
Source images 
 In this study we collected images: a computer generated helical and straight line 
phantom (Fig. 2.1 A, B), two computer generated branching phantoms with background 
noise from Aylward (Aylward and Bullitt, 2002) (Fig. 2.2 A, B) and eight human brain 
Time of Flight (TOF)-MRA images (Fig. 2.3). The helical phantom was generated by 
calculating points on a helical and straight lines then rolling a ball with a 6 voxel radius 
along the points. The eight MRA image data sets were selected from our ongoing 
intracranial aneurysm study approved by the University of Utah Institutional Review 






 Image processing tools for this study were developed in Java with the ImageJ 
toolkit (Rasband, 1997; Burger and Burge, 2007). Results were stored in the MySQL 
database (available at http://www.mysql.com/). Graphing results and statistical analysis 
were performed with R (R Development Core Team, 2009) . 
Segmentation 
 The unsegmented computer generated branching phantoms and the eight human 
brain MRA images were segmented from the background noise and brain tissue leaving 
the simulated arterial tissue (Fig. 2. 4 A, B) or the human brain arterial tissue (Fig. 2.5) 
with a z-buffer segmentation (ZBS) algorithm (Parker et al., 2000; Chapman et al., 2004). 
The point where the three branches of the branching phantoms meet is narrow so that the 
region growing threshold employed during the ZBS segmentation had to be lowered in 
order to keep the segmented branches all in one connected component (Fig. 2.4 B). 
Additional details of the segmentation process are covered in the Segmentation 
supplement section. The result of segmentation is the extracted arterial tree.  
Cost function segmentation preprocessing 
 To generate a centerline through the segmented arteries a cost was assigned to 
every voxel (a three-dimensional pixel) in the extracted arterial tree. Four different costs 





 The MDFEi cost function calculates a value for each voxel that is higher for 
voxels closer to the edge of the arteries and lower for voxels closer to the middle of the 
arteries by first calculating the distance from edge (DFE), modifying the DFE (MDFE) to 
break ties and inverting to make the costs higher on the outside and lower on the inside 
(Zhang et al., 2005) (Fig. 2.6). 
 The center of mass cost function loops through every voxel in the segmentation 
and calculates the average X, Y and Z positions of each voxel and up to 26 three-
dimensional neighbors as the center of mass, recording each voxel’s center of mass and 
cumulative distance moved from the original position to each subsequent center of mass 
through multiple iterations. At each iteration, the center of mass calculation depends on 
the positions of the previous iteration. The center of mass calculation is repeated until all 
voxels have been moved a minimum of 30 times. Increasing iterations increased stability 
only minimally after 30 iterations. The cumulative distances moved are divided by the 
minimum nonzero distance moved in the entire segmentation and the result is cubed. 
Voxels at the segmentation edge begin moving with the earliest iterations and tend to 
move the farthest, generating high cost scores. Voxels near the center move with later 
iterations and for short distances, generating low cost scores (Fig. 2.7). 
 The BT centerline algorithm (Homman, 2007) eroded the segmentations to single 
voxel-width skeletons (Fig. 2.8 A, B and Fig. 2.9). The brain artery skeletons are close to 
centerlines but have short segments running across wide arteries (Fig. 2.9). The skeletons 
were used as inputs into the MDFEi or COM cost functions to utilize the existing 





always be one for every voxel and not change the skeleton. The voxels will typically only 
have 1, 2 or 3 neighbors in the COM reducing the amount of movement compared to the 
earlier algorithms. 
 The result of preprocessing are cost values for every voxel in the extracted arterial 
tree. The costs will be higher at the edge and lower in the middle. The binary thinned 
arteries will only have one cost value. The centerline of the arteries will be the lowest 
cost path through the cost function.  
Centerline algorithms 
 To calculate the centerline the precomputed arterial tree costs were input into the 
Dijkstra shortest paths algorithm (Dijkstra, 1959). Dijkstra’s algorithm calculated the 
lowest cost centerlines from every voxel back to a selected starting root voxel. Then the 
paths less than 30 voxels long were removed leaving a skeleton centerline of the arterial 
tree (Zhang et al., 2005). The root of the MDFEi based centerline trees was the maximum 
MDFE, the thickest point in the arterial tree (Zhang et al., 2005). The root of the BT-
MDFEi based centerline tree was the most central voxel in the arterial tree. The root of 
the COM based centerline tree and binary thinning-center of mass (BT-COM) based 
centerline trees are voxels with the lowest center of mass score. In the event of tied 
starting root points the root closest to the center of the image was selected. The 
centerlines tend toward the lower cost middle voxels of the preprocessed segmentations 
(Fig. 2.10 A, B). Shortest paths centerline generation on the binary thinned input has the 





results of the centerline algorithms were single voxel width centerline skeletons of the 
arterial trees.  
Stability measure 
 Stability of the centerline was measured by generating the centerlines for the same 
segmentation starting at different root points. The first centerline tree is initiated from the 
root as described for the centerline algorithms. The arterial tree endpoints of the largest 
connected centerline tree were used as roots for a second round of centerlines. Smaller 
centerline trees of segmented arteries not connected to the largest section were discarded. 
 To measure and identify stable and unstable centerlines, the first round and all 
second round centerlines were accumulated in one image. The most stable centerline 
points occur in the same voxel for all N centerline root points. The stability measure for 
an image was the percentage of centerline voxels in the accumulated image called 
centerline for all of the centerline roots. 
 To visualize the accumulated centerlines the inverse of the accumulation was 
plotted in 3-D with the surrounding segmentation. This makes unstable voxels that are 
called centerline by fewer than N roots brighter than their neighbors and therefore easily 






 Accuracy of the centerlines of the phantoms is measured by the root mean square 
error (RMSE) of Euclidean distances from the algorithm generated centerline points to 
the nearest known centerline point for a phantom. The centerline points used to generate 
the helix line phantom were known. The known centerline points for the helix line 
phantom were sparse (Fig. 2.1B); the algorithm-derived centerlines had more points 
because the centerlines extend out to last voxel at the end while the known center points 
used to generate the phantom stop at one radius distance from the edge of the phantom as 
seen in Fig. 2.1B. Therefore, the RMSE was computed only over the set of known points 
and their nearest centerline determined neighbors. Aylward and Bullitt (Aylward and 
Bullitt, 2002) provided ideal subvoxel accuracy positive control centerline coordinates, 
available in a text file, for the branching phantoms with noise. The RMSE of these 
phantoms was calculated between each centerline point determined by the Dijkstra 
algorithm and the closest subvoxel positive control point. The accuracy of the helix line 
phantom was visualized by plotting each algorithm centerline coordinate in red 
accumulating for each starting root and plotting the positive centerline control points in 
green. The red and green color together made yellow showing where the algorithm and 






Phantom centerline stability and accuracy 
 The centerline tree of first helix line phantom (Fig. 2.1B) had seven ends. The 
first starting point in the thickest point of the phantom followed by starting points at the 
seven ends made total of eight centerline trees for the stability analysis. In this case, the 
inverse MDFEi cost function was the least stable with the lowest stability score (Table 
2.1). Instability occurred throughout the helix at bifurcations and at line ends (Figure 2.12 
A). The binary thinning skeleton only left one possible highly stable centerline with some 
instability occurring at ends when the skeleton was passed to either the inverse MDFEi or 
COM programs. The COM based centerline was more stable (higher stability score) than 
the inverse MDFEi based centerline (Table 2.1). 
 The MDFEi cost function was the most accurate (lowest RMSE) despite being the 
most unstable (lowest stability score) (Table 2.1). The accuracy visualization shows the 
positive control green, algorithm red and overlapping yellow centerlines (Fig. 2.12 right 
column). The inaccuracies occur at ends and bifurcations and in the helix portion of the 
phantom. The locations of the inaccuracies are similar to the locations of instability (Fig. 
2.12). The COM based centerline lost more accuracy than the other algorithms bending 
around bifurcations as seen by the green color in Fig. 2.12 D. The binary thinning 
algorithms were frequently a few voxels off as seen by the green in the helix (Fig. 2.12 F, 





Stability and accuracy on phantoms with noise 
 The MDFEi based centerline algorithm had the lowest stability and best accuracy 
(lower RMSE) for the lower SD 10 noise phantom. For the higher SD 20 noise phantom 
the COM and binary thinning paired with COM had lower RMSE. Binary thinning 
followed by the COM based algorithm consistently outperformed binary thinning 
followed by the MDFEi based algorithm with higher stability scores and lower RMSE of 
accuracy. Therefore the rest of the trials on MRA data used the binary thinning followed 
only by the COM based algorithm for centerline generation. The number of primary (one) 
plus secondary starting root points was three for most algorithms and four for the binary 
thinning followed by the COM based algorithm because the initial start point for the first 
round centerline was near an end of the branching object for the tests with three starting 
roots. The binary thinning followed by COM had the highest stability besides having the 
extra centerline tree (Table 2.2). The bright end of the lower right branch in Fig. 2.13 B 
shows that much of COM based algorithm instability happens at the end of the branch 
because one of the starting roots occurred here, shortening the centerline. When the 
centerline was rooted at another branch end the centerline extended longer at this branch 
end. This was an example of how the starting point alters the centerline tree. 
Artery centerline stability 
 The running time for calculating COM costs for arterial trees was under 60 
seconds for a total time of 3 to 5 minutes to generate the centerlines for all the centerline 





instability was seen in the left internal carotid artery in Fig. 2.14 A. In the vessel 
segmentation, the internal carotid artery siphon frequently loops back and touches itself 
creating a shortcut for the centerline to pass through. The MDFEi based centerlines pass 
through the kissing point (Fig. 2.15 A and Fig. 2.16 B). Dijkstra's shortest paths on the 
segmentation cost functions of the MDFEi and COM based algorithms produce only 
nonlooping branches. In the MDFEi based algorithm, the first centerline passes through 
the kissing point and subsequently two centerlines extend out from the kissing point to 
end on the distant edges of the siphon arterial wall (Fig. 2.14 A and B and Fig. 2.16 B). 
The COM based algorithm produced high scores near the kissing point, even though the 
scores in the kissing point are low (Fig. 2.15 B), causing the first centerline to run around 
the siphon loop (Fig. 2.14 C, D and Fig. 2.16 B). Shorter centerlines are subsequently 
generated by Dijkstra's algorithm (Dijkstra, 1959) from the kissing point to end at the 
longer centerline. However, these shorter centerlines fall below the 30 voxel length 
threshold and are removed leaving the final centerline tree (Fig. 2.16 B). The BT-COM 
based centerline consistently forms a loop with one part of the centerline passing through 
the narrow kissing point (Fig. 2.14 E, F and Fig. 2.16 C). Failing to pass a centerline 
through the internal carotid artery (ICA) siphon loop is a common centerline failure and 
is used as a measure of centerline accuracy in the MRI images since there is no gold 
standard centerline for computing the RMSE as with the earlier phantoms. 
 As with the phantoms the COM and BT-COM based centerline had higher 
stability than the MDFEi based centerlines. We recorded when the centerline succeeded 





passed through the ICA without touching the edge of the segmentation for all roots; any 
failure of one tree was counted as a failure. The MDFEi based centerline would 
frequently pass through the ICA siphon correctly for some starting root locations but not 
others leading to its lower mean stability measure. 
 A one-way analysis of variance (ANOVA), using the lm command from R (R 
Development Core Team, 2009), of the centerline accuracy in the 16 ICA siphons by 
algorithm (MDFEi, COM, BT-COM) showed a significant difference p-value = 3.62e-04. 
The COM was significantly more accurate than BT-COM, p-value = 1.26e-02. BT-COM 
was more accurate than MDFEi but not significantly different, p-value = 9.01e-02. 
 One-way ANOVA showed the algorithm significantly affects the stability, p-
value = 1.63e-06. As the centerline stability box and whiskers plot shows the BT-COM 
based algorithm and COM algorithm are very close in stability, p-value = 0.846 
indicating no significant difference. The MDFEi algorithm produces a significantly less 
stable centerline than the BT-COM based algorithm, p-value < 0.0001 (Fig. 2.17 A and 
Table 2.4). 
 The first run of different centerline algorithms can produce differing numbers of 
tree ends for roots of following centerline trees generated to measure stability. More ends 
and more centerline trees create more opportunity for instability. The centerline 
algorithms did not produce significantly different numbers of tree ends (p-value = 0.862). 
The number of tree ends used as roots does not account for the instability of the MDFEi 
centerline algorithm as seen in Fig. 2.17 B and Table 2.4. Table 2.4 summarizes the 






 Our study showed the COM based centerline algorithm was more stable and 
correctly calculated more centerlines around the kissing ICA loops than the other 
algorithms tested using the newly developed centerline stability measure and 
visualization of ICA loop centerline. The stability measurement strategy demonstrated 
the consistency of the COM based centerline algorithm in the kissing ICA loops. The 
stability measurement strategy of starting the centerline tree at different points can be 
reused to test other centerline algorithms for use on any tubular structure. The stability, 
and phantom accuracy, visualization methods developed here identified where inaccuracy 
and instability were occurring. These methods are also usable for a wide range of 
centerline algorithms and applications of centerlines to anatomical studies. 
 This study is a first attempt to address the problem of kissing vessels. Kissing 
blood vessels are common in the segmentations of the brain and other anatomy. The 
method of having the centerline follow the middle of the mass of the artery solved the 
kissing vessel problem in the ICA loop in this study. Using mass in the centerline 
algorithm will be useful in any anatomical case where the true anatomical centerline is in 
the largest mass and noise creates smaller adjacent structures to the vessel. 
 The measure of stability from multiple starting points was able to determine the 
COM based algorithm handled the ICA kissing siphon from all starting ends ensuring the 
stability of the algorithm. It would be computationally impractical to test stability by 
starting the stability measure from every point in the segmentation or even from every 





centerline tree the centerline algorithm will approach the regions of instability such as 
kissing ICA loop and all bifurcations from all directions thus testing the algorithm from 
all directions. The visualization of stability and accuracy allowed us to see that the 
instabilities and inaccuracies are mainly occurring at kissing vessel points and 
bifurcations. 
 The COM based centerline algorithm generates correct centerlines in cases where 
the artery is much larger than the kissing points and is resistant to adjacent segmentation 
noise as long as the noise is smaller than the artery. The COM based centerline gravitates 
toward the center of the largest mass and in the case of the ICA siphon the largest mass is 
in the loop and kissing section is smaller contributing less to the center of the mass. 
 All the cost functions had inaccuracies in the loop of the helix. The curve of the 
helix in the phantom is approximated to the nearest voxel and the centerline algorithms 
also have to approximate voxel positions causing the inaccuracies and instability 
frequently seen in curving centerlines. Curved centerlines often have a stair-stepped 
appearance. Some applications of the centerline may require subvoxel smoothing of the 
centerline to obtain smooth curves. 
 A limitation of comparing centerline algorithms by stability is that the most 
accurate centerline algorithm was not always the most stable algorithm. The BT 
algorithm was inherently stable because it erodes the segmentation from all outside points 
simultaneously to a single skeleton line. The BT cost functions, paired with MDFEi or 
COM, had consistently high stability while not having the highest accuracy in the 





algorithm removed most voxels of the segmentation in the skeletonization step leaving a 
limited path for the centerline generation from the skeleton allowing the BT algorithms to 
maintain high stability. 
 Highest stability also did not correspond to highest accuracy in the no noise and 
low noise phantoms where the MDFEi based algorithm was least stable but most 
accurate. In the brain images the COM based algorithm was clearly most accurate in the 
ICA siphon and was not significantly less stable than the most stable BT-COM based 
algorithm, while having the lowest stability in all phantoms and brain images the MDFEi 
based centerlines were the most accurate in the no added noise helix line phantom (Figure 
2.1 A, B) and low SD 10 noise (Figure 2.2 A) phantoms. The RMSE of accuracy of the 
MDFEi centerlines increased from 0.393 in the SD 10 noise phantom to 0.674 in the SD 
20 noise phantom (Table 2.2), a greater increase than the other more stable COM, BT-
MDFEi and BT-COM based algorithms. It makes sense that the least stable centerline 
would lose accuracy the fastest as noise increases. As noise increases the stability of the 
algorithm becomes increasingly important to maintaining accuracy. The MDFEi based 
centerlines were the least accurate in the ICA siphons of the brain images that contain the 
noise of the MRI. 
 The current study tested a limited number of centerline algorithms both internally 
and externally developed. The stability measure and visualization of inverse stability are 
usable by researchers testing algorithms for particular centerline extraction applications 
of tubular anatomy. There may not be an ultimate singular centerline algorithm suitable 





the ICA siphon loop is prone to missing small dim arteries near larger brighter arteries. 
An application looking at a small dim artery would have to use another algorithm making 
the availability of comparison methods important. Tubular structures occur frequently in 
anatomy. In addition to the arteries studied here other anatomical structures studied with 
centerlines include veins, lung bronchioles, large and small intestine, nerves, bones and 
any other tubular anatomical structures. 
Conclusion 
 Centerlines can be used to measure features of tubular anatomical structures. This 
study expands the range of structures that can have a centerline calculated. The kissing 
ICA siphon loops could not have a centerline made with the existing MDFEi (Zhang et 
al., 2005) and BT (Homman, 2007) algorithms. The COM algorithm developed here 
made a centerline possible in the ICA siphon loop. The centerline stability measure 
showed that the COM algorithm handled the kissing ICA siphon starting from any 
direction showing that the COM algorithm is stable in this case. The stability measure 
can be reused to test centerline algorithms when evaluating centerline algorithms for 
other tubular anatomical structures. 
Acknowledgements 
 We greatly appreciate the help of the staff at the Utah Center for Advanced 





 The branching phantoms used in this paper were generated and made available by 
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Figure 2.1. Electronic phantoms. (A) Shaded surface rendering of phantom. (B) 
Maximum intensity projection of phantom with centerline points used to generate 
the phantom. 
 
Figure 2.2. Aylward phantoms with background intensity 100 and tubular objects 
with cross-sectional intensities in a parabolic profile ranging from 150 at the 
edge to 200 at the middle of the object with increasing Gaussian noise. (A) Phan-







Figure 2.3. Magnetic resonance angiography (MRA) images of patient from 3 T 
MRI scanner viewed from the top with background brain tissue. 
 
Figure 2.4. MIP projects of the segmented computer generated branching phan-
toms. (A) SD 10 segmentation with the seed histogram region growing threshold 
set at 0.15. (B) SD 20 segmentation with the seed histogram region growing 






Figure 2.5. Segmented arteries shaded surface depth image shows the segmenta-
tion in 3D. 
 
Figure 2.6. Brain artery segmentation inverse Modifed Distance From Edge 
(MDFEi) cost function score cross section. Brighter is higher cost, darker is 
lower cost. 
  
Figure 2.7. Brain artery segmentation Center Of Mass (COM) cost function score 
cross section. Brighter is higher cost, darker is lower cost.
Figure 2.8. Binary thinned phantoms. (A) SD 10 binary thinned skeleton. (B) SD 








Figure 2.9. Maximum intensity transverse projection of binary thinned arteries. 
Binary thinning of segmen










Figure 2.10. Cross sections of centerlines in artery segmentation cost functions. 
The centerlines line in the low cost darker middles of the segmented arteries. (A) 








Figure 2.11. Maximum intensity transverse projection of binary thinned arteries. 
The skeleton is turned into a centerline by processing the skeleton with Dijkstra's 
shortest paths algorithm and removing lines less than 30 voxels long. The final 











Figure 2.12. Phantom stability and accuracy (A
racy visualization. A,C,E,G maximum intensity projection (MIP) of stabil
ages. B, D,F,H shows zoomed in and rotated MIP images of accuracy images to 
show where the known green centerlines differ from the red algorithm cente
lines and were they overlap in yellow. A
COM algorithm, E-F is the BT
rithm. 
 
-H) Phantom stability and acc
- B is the MDFEi algorithm, C
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Figure 2.13. Stability images showing the inverted stability centerlines of the 
branching phantom with SD 20 Gaussian noise. (A) MDFE
segmented image. (B) COM stability lines on the segmented image. (C) BT
MDFEi stability on the skeleton. (D) BT
 
 
i stability lines on the 




Figure 2.14. Maximum intensity projections of stability images show the cente
line instability brightly. (A) MDFE
MDFEi cost scoring the centerline passes through the kissing ICA siphon. (C) 
COM algorithm centerline transverse MIP. (D) COM cost scoring the centerline 
takes the larger wider loop around the ICA siphon in
point. (E) BT-COM centerline transverse MIP. (F) BT
through kissing vessel loop.
 
 
i algorithm centerline transverse MIP. (B) 
stead of the narrow kissing 







Figure 2.15. Cost function cross sections
showing a kissing ICA siphon loop with the centerline passing through. (B) The 










Figure 2.16. Stability MIP images of segmented kissing ICA siphon loop. (A) 
Shaded surface depth image of ICA loop shows thin kissing point. (B) MDFE
centerline passes through narrow kissing point. (C) COM centerline draws line 
around low scoring siphon loop. A centerline is m
point but is removed by thresholding to eliminate short centerline lines segments. 
The COM centerline appears to come closer to the inside edge than the outer 





ade through the narrow kissing 





Figure 2.17. Algorithm stability
instability of the MDFEi (labeled DFE) centerline algorithm compared to COM 
and BT-COM centerline algorithms. (B) The three ce




 (A) Box and whiskers plot showing the greater 









Table 2.1. Helix line phantom stability and accuracy 
Algorithm Stability RMSE of Accuracy 
MDFEi 0.880 0.240 
COM 0.980 0.610 
BT-MDFEi 1.000 1.833 
BT-COM 1.000 1.830 
 
Table 2.2. Comparison of algorithm stability and accuracy on phantoms 
Phantom Algorithm Number of 
trees 
Stability RMSE of Accuracy 
SD 10 MDFEi 3 0.930 0.393 
SD 10 COM 3 0.960 0.463 
SD 10 BT-MDFEi 3 0.910 0.438 
SD 10 BT-COM 4 1.000 0.437 
SD 20 MDFEi 3 0.946 0.674 
SD 20 COM 3 0.950 0.528 
SD 20 BT-MDFEi 3 0.920 0.519 
SD 20 BT-COM 4 1.000 0.457 
Stability and accuracy comparison of the MDFEi, COM, BT-MDFEi and BT-
COM algorithms on branching tubular phantoms with standard deviation (SD) 10 
and 20 distributed Gaussian noise. 










































































































MDFEi 6/16 0.375 1/8 38.875 14.672 0.677 0.076 
COM 16/16 1.000 8/8 35.125 13.314 0.877 0.042 
BT-COM 10/16 0.625 4/8 37.500 13.617 0.883 0.068 
Comparison of centerline stability, number of centerline tree roots and correct-
ness of the centerline through the internal carotid artery (ICA) siphon between 





Table 2.4. Means by algorithm 
Algorithm Mean stability Mean number of trees 
BT-COM 0.88275 37.50000 
COM 0.87650 35.12500 




















445 40 0.692 38 0.867 38 0.903 
443 53 0.644 41 0.909 41 0.937 
136 41 0.641 37 0.886 39 0.842 
20 34 0.673 28 0.924 30 0.882 
49 65 0.529 62 0.848 65 0.740 
807 19 0.762 18 0.793 23 0.953 
788 33 0.713 33 0.879 42 0.877 








Arimura H, Li Q, Korogi Y, Hirai T, Abe H, Yamashita Y, Katsuragawa S, Ikeda R, and 
Doi K. 2004. Automated computerized scheme for detection of unruptured intracranial 
aneurysms in three-dimensional magnetic resonance angiography. Acad Radiol 11:1093-
104. 
Aylward SR, and Bullitt E. 2002. Initialization, noise, singularities, and scale in height 
ridge traversal for tubular object centerline extraction. IEEE Trans Med Imaging 21:61-
75. 
Bullitt E, Gerig G, Pizer SM, Lin W, and Aylward SR. 2003. Measuring tortuosity of the 
intracerebral vasculature from MRA images. IEEE Trans Med Imaging 22:1163-1171. 
Burger W, and Burge MJ. 2007. Digital Image Processing: An Algorithmic Introduction 
using Java. 1st ed. Springer. 
Chapman BE, Stapelton JO, and Parker DL. 2004. Intracranial vessel segmentation from 
time-of-flight MRA using pre-processing of the MIP Z-buffer: accuracy of the ZBS algo-
rithm. Med Image Anal 8:113-26. 
Cormen TH, Leiserson CE, Rivest RL, and Stein C. 2009. Introduction to Algorithms, 
Third Edition. 3rd ed. The MIT Press. 
Dijkstra EW. 1959. A note on two problems in connexion with graphs. Numerische 
Mathematik 1:269-271. 
Farnham JM, Camp NJ, Neuhausen SL, Tsuruda J, Parker D, MacDonald J, and Cannon-
Albright LA. 2004. Confirmation of chromosome 7q11 locus for predisposition to intrac-
ranial aneurysm. Hum Genet 114:250-5. 
Frangi AF, Niessen WJ, Hoogeveen RM, van Walsum T, and Viergever MA. 1999. 
Model-based quantitation of 3-D magnetic resonance angiographic images. IEEE Trans 
Med Imaging 18:946-956. 
Hiroki M, Miyashita K, and Oda M. 2002. Tortuosity of the white matter medullary arte-
rioles is related to the severity of hypertension. Cerebrovasc. Dis 13:242-250. 
Homman H. 2007. Insight Journal - Implementation of a 3D thinning algorithm. Avail-
able from: http://www.insight-journal.org/browse/publication/181 
Kang D-G, Suh DC, and Ra JB. 2009. Three-dimensional blood vessel quantification via 





Lesage D, Angelini ED, Bloch I, and Funka-Lea G. 2009. A review of 3D vessel lumen 
segmentation techniques: models, features and extraction schemes. Med Image Anal 
13:819-845. 
O’Flynn PM, O’Sullivan G, and Pandit AS. 2007. Methods for three-dimensional geo-
metric characterization of the arterial vasculature. Ann Biomed Eng 35:1368-1381. 
Parker DL, Chapman BE, Roberts JA, Alexander AL, and Tsuruda JS. 2000. Enhanced 
image detail using continuity in the MIP Z-buffer: applications to magnetic resonance 
angiography. J Magn Reson Imaging 11:378-88. 
R Development Core Team. 2009. R: A language and environment for  statistical com-
puting. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. 
Available from: http://www.R-project.org/ 
Rasband W. 1997. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA. 
Available from: http://rsb.info.nih.gov/ij/ 
Zhang L, Chapman BE, Parker DL, Roberts JA, Guo J, Vemuri P, Moon SM, and Noo F. 
2005. Automatic detection of three-dimensional vascular tree centerlines and bifurcations 









 The sample objects used for testing segmentation and centerline algorithm 
stability and accuracy included artificial phantom data and eight Time of Flight (TOF) 
MRA image data sets. A binary valued helix line phantom was created by propagating a 
sphere along a path defined by straight lines and helices. Two computer generated 
branching gray-scale phantoms with background intensity 100 and tubular objects with 
cross-sectional parabolic intensity profiles ranging from 150 at the edge to 200 at the 
middle of the artery with added Gaussian noise of standard deviation 10 and 20 were 
obtained from (Aylward and Bullitt, 2002). 
 The eight MRA image data sets were selected from our ongoing intracranial 
aneurysm study approved by the University of Utah Institutional Review Board. Three of 
the eight subjects were selected from high aneurysm risk family pedigrees (Farnham et 
al., 2004). Six subjects have intracranial aneurysms, including the three high-risk 
subjects. The patients were imaged with TOF-MRA on a Siemens TIM Trio 3.0 T MRI 
scanner. The images were acquired with anisotropic voxels (0.3 X 0.3 X 0.6mm3) and 
were zero fill interpolated by a factor of 2 in all directions for final dimensions of 0.15 X 
0.15 X 0.3 mm3. 
Segmentation 
 Each artery segmentation takes approximately 3 to 5 minutes on a 2.83 GHz Intel 





were segmented from the background using a Z-buffer segmentation and region growing 
method (Parker et al., 2000). In the Z-buffer segmentation (ZBS) algorithm, the Z-buffer 
stores the location (Z) along the project direction of the brightest point in the image along 
each ray. In a Z-buffer image formed by displaying the locations of the brightest voxels, 
voxels that project from arteries appear smoothly connected because there is a high 
probability that the high intensity vessel voxels will project and that adjacent projections 
will select voxels in close axial proximity. In extended regions of uniform signal where 
voxels project from background and other nonvessel tissues the Z-buffer image tends to 
appear noisy because there is little probability that voxels in adjacent projections share 
similar axial positions in the source image volume. Seed voxels for region growing are 
obtained by joining smoothly connected voxels in the Z-buffer. The smaller phantoms 
used seeds of 10 connected voxels and the larger brain images used seeds of 30 
connected voxels. The 3D segmentations are completed by intensity-based region 
growing in the source images starting from the ZBS seed and iteratively adding voxels 
with intensity over a threshold. For the brain MRA images the region-growing threshold 
is determined from a histogram of the seed intensities as the maximum intensity of the 
bottom 15 percentile of the seed intensities. The seed threshold was selected to fill large 
aneurysms in our image collection. 
 The resulting vessel segmentations often contained internal holes in regions of 
low signal intensity in the source images caused by slow or recirculating blood flow. 
Holes were filled by finding empty bubbles completely surrounded by arterial voxels as 





filling step, individual voxels were filled in that had 21 of 26 neighboring arterial voxels 
within a radius of 3 voxels as in (Zhang et al., 2005). This hole filling was repeatedly 
applied 3 times and then completely surrounded bubbles were filled once more. The hole 
filling parameters were selected to completely fill aneurysms in the tested subjects. 
 To eliminate small kissing arteries in the brain image segmentations, voxels less 
than 0.3 mm from the external surface of the segmented vessels were deleted from the 
segmentation. The voxel size is this study is 0.15 X 0.15 X 0.3 mm3. Therefore all voxels 
less than 0.3 mm from the edge of the segmentation were removed, meaning that one 
voxel in the transverse x, y plane is removed. This reduced segmentation noise and only 
resulted in the loss of smaller peripheral blood vessels. This was acceptable because our 
study focused on the performance of centerlines in the region of the carotid siphon.  
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 Hypertension may increase tortuosity or twistedness of arteries. We applied a 
centerline extraction algorithm and tortuosity metric to magnetic resonance angiography 
(MRA) brain images to quantitatively measure the tortuosity of arterial vessel centerlines. 
The most commonly used arterial tortuosity measure is the distance factor metric (DFM). 
This study tested a DFM based measurement’s ability to detect increases in arterial 
tortuosity of hypertensives using existing images. Existing images presented challenges 
such as different resolutions which may affect the tortuosity measurement, different 
depths of the area imaged, and different artifacts of imaging that require filtering. 
Methods 
 The stability and accuracy of alternative centerline algorithms was validated in 
numerically generated models and test brain MRA data. Existing images were gathered 
from previous studies and clinical medical systems by manually reading electronic 
medical records to identify hypertensives and negatives. Images of different resolutions 
were interpolated to similar resolutions. Arterial tortuosity in MRA images was measured 
from a DFM curve and tested on numerically generated models as well as MRA images 
from two hypertensive and three negative control populations. Comparisons were made 
between different resolutions, different filters, hypertensives versus negatives, and 






 In tests using numerical models of a simple helix, the measured tortuosity 
increased as expected with more tightly coiled helices. Interpolation reduced resolution-
dependent differences in measured tortuosity. The Korean hypertensive population had 
significantly higher arterial tortuosity than its corresponding negative control population 
across multiple arteries. In addition one negative control population of different ethnicity 
had significantly less arterial tortuosity than the other two. 
Conclusions 
 Tortuosity can be compared between images of different resolutions by 
interpolating from lower to higher resolutions. Use of a universal negative control was 
not possible in this study. The method described here detected elevated arterial tortuosity 
in a hypertensive population compared to the negative control population and can be used 
to study this relation in other populations. 
Background 
 There is evidence that hypertension can affect blood vessel morphology. 
Increasing stage of hypertension has been shown to correlate with increased tortuosity or 
twistedness of white matter arterioles in autopsy photomicrographs [1]. In vitro studies 
on extracted dog arteries showed increasing blood pressure caused increases in tortuosity 





lenticulostriate arteries visible in Magnetic Resonance Angiography (MRA) images 
decreased in hypertensive subjects compared to negative controls, an increase in 
tortuosity was not seen in tortuosity measurements made on 2D projections of the 3D 
data [3].  
 Tortuosity measurement has the potential to quantify morphological changes in 
arteries due to hypertension. Tortuosity can be measured from MRA images of arteries. 
The process starts with MRA imaging of arteries, segmentation of arteries, calculation of 
centerlines, and calculation of tortuosity from the centerlines. Centerlines simplify 
arteries and other tubular structures to a single line passing through the middle of the 
artery making measurement of length and position possible. Measurements on the 
centerlines can be used to calculate tortuosity scores.  
 The most commonly used tortuosity measure is the distance factor metric (DFM) 
that requires two end-points to measure the ratio of the length L along the centerline and 
the distance d between two end-points [4-10]. The DFM suffers some weaknesses. Some 
arteries only have one anatomical end-point in an image volume and local tortuosity 
scores can rise and fall along an artery. The DFM can miss local tortuosity depending on 
the selection of the two end-points. Furthermore, the comparison of DFM tortuosity 
between multiple subjects can be challenging when the image volumes do not all share 
the same two anatomical centerline end-points. 
 Centerlines can be calculated by Dijkstra's algorithm [11] which finds the shortest 
or lowest cost path from any given point in the arterial segmentation to a selected goal 





assigned a cost based on its position with respect to the goal. The longest lowest cost 
paths from the distal ends of the arteries back to a central goal node are the centerlines 
[12]. The selection of the central goal node and cost function can affect the path of the 
centerline.  
 Existing images from previous studies and clinical scans provide a large set of 
data for analysis that saves the time and cost of acquiring new images. Reusing existing 
images for comparison studies may present difficulties if the images have been acquired 
with different parameters including the field strength of the magnetic resonance imaging 
(MRI) scanner, resolution, and field of view (FOV) placement. FOV placement may 
affect whether the same artery segments are seen in both views. Differences in resolution 
may affect the tortuosity measure. Some vessels visible in MRA images from high 7.0 T 
field strengths may not be seen at lower resolution and the high field may cause phase 
flow artifacts [13, 14] that can be mistaken for arteries by centerline algorithms, requiring 
pre- or postprocessing for removal. Filtering can cause data loss and could affect the 
tortuosity measure. Negative controls may be obtained from existing images from 
patients with nonvascular diseases but proof of being truly negative is needed.  
 Testing of centerline and tortuosity measurement algorithms can be conducted on 
numeric phantoms. Numeric phantoms are three-dimensional shapes generated by 
equations in computer software with known morphology and centerlines. Algorithm 
calculated centerlines can be compared to known centerlines to assess accuracy and 





 In this study we first test the stability and accuracy of our Dijkstra’s shortest path 
centerline algorithms by using different cost functions and goal node voxels on numeric 
phantoms and a sample of brain MRA images. We modified the classical DFM tortuosity 
measurement to create a tortuosity curve that provides additional information and tested 
the measurement on numeric phantoms. We applied the DFM tortuosity curve 
measurement to existing brain MRA images. The images included data on the same 
subjects filtered for noise with different filters and at different resolutions to test the 
effects of filtering and resolution on tortuosity. Hypertension data from the Korean 
hypertension study [3] and clinical hypertension data from Utah were tested to determine 
if the method can detect a correlation between hypertension and tortuosity of the arteries 
visible in MRA images. Tortuosity was also compared between three negative controls to 
test similarity and determine if universal negative controls can be used.  
Methods 
Image analysis flow 
 The image data are analyzed by interpolation, filtering, segmentation, centerline 
extraction, tortuosity curve calculation, and reading of the tortuosity score. The 
interpolation and filtering were optional steps. Segmentation was not needed in numeric 





Centerline cost functions 
 Cost functions for input into Dijsktra’s shortest path centerline algorithm included 
the modified distance from edge (MDFE) cost, center of mass (COM) and distance from 
edge (DFE)-COM. The DFE measures the distance of each segmented voxel to the 
nearest edge of the artery. The DFE exhibits a degeneracy which can interfere with 
centerline extraction: adjacent voxels may be equally distant from their nearest respective 
edges. The DFE is essentially a one-dimensional measure, ignoring all other edge 
locations but one in its calculation. The MDFE was developed [12] to use local spatial 
information to break ties between adjacent voxels with the same DFE values.  
 The COM function is computed by iteratively moving each voxel toward the 
current COM of its adjacent neighbor voxels, effectively collapsing the object inward. 
For the objects considered in this study, 30 iterations of motion toward the center of mass 
were sufficient. Each iteration uses the previous iteration’s mean positions and the 
cumulative distance moved by each voxel is recorded. To calculate the COM cost for 
each voxel, the cumulative distances moved were divided by the minimum nonzero 
distance moved in the entire segmentation and the result was cubed. Voxels at the 
segmentation edge moved farther, generating higher cost and voxels near the center 
moved shorter distances, generating lower costs. Because the COM calculation depends 
on the relationship between each voxel and its neighbors, it is highly sensitive to the 






 The DFE-COM cost function combines the two cost functions. During the 
iterations of the COM algorithm, rather than assigning uniform weights to neighbor 
voxels, a weighted center of mass was computed using the DFE values as weights. 
Weighting gave more influence to the voxels with higher DFE in the middle of arteries 
when calculating the COM cost function. 
Numeric phantom generation 
 Numeric phantoms were generated by beginning with defined single point width 
centerlines. The centerlines were then discretized and placed within a discrete image 
volume. All voxels within a predefined radius of the centerline voxels were identified as 
object voxels, simulating imaged arteries. A subset of the discrete centerline locations 
were then used as positive controls for comparison with subsequent centerline extraction 
(Figure 3.1).  
Centerline stability and accuracy 
 The stability and accuracy of the DFE-COM cost-function centerline algorithm 
was measured and compared to the separate MDFE and COM cost function centerline 
algorithms on a set of numeric phantoms. The first numeric phantom considered was a 
comb phantom with a three voxel radius. A second series of branching phantoms with 





stability and ability of each algorithm to calculate centerlines around the internal carotid 
artery (ICA) siphon loop were tested with eight 3.0 T brain MRA image volumes.  
Tortuosity measurement 
 Tortuosity was determined at every point along the selected centerlines with the 
DFM [5, 8] creating tortuosity curves. A single tortuosity measure was taken from each 
tortuosity curve either at the end of centerline or where the DFM was a maximum. 
Selection of the DFM value depended upon properties of the arteries being measured and 
is described in detail later.  
Tortuosity measurement of phantoms 
 The DFM tortuosity measurement was tested on 3-D numeric helix phantoms of 
increasing pitch with the DFE-COM centerline tortuosity measurement. The helix 
phantoms were generated by drawing a line with the equation h(t) = [r*cos(t), r*sin(t), 
(p*t)/(2π)] where r was the helix radius and p was the pitch of the helix and the radius of 
the simulated arterial width was 6 voxels. The helix radius r was fixed at 100 and four 
helices were generated with pitches 5(2π), 10(2π), 20(2π) and 40(2π) (Figure 3.2). The 







 The arteries in the MRA images were segmented from background (Figure 3.3) 
using the Z-buffer segmentation (ZBS) algorithm [16]. ZBS algorithm works based on 
the assumption that arteries are the brightest structures in the image, they are sparsely 
represented in the image volume, and that bright artery voxels will be spatially close 
together. The algorithm casts rays in the Z axis through the 3D image volume finding the 
z-position of the brightest voxel in each ray. The z-positions of clusters of brightest 
voxels are then used as seeds for region growing and artery segmentation [16]. The artery 
segmentation is grown from the seed voxels by iteratively adding all neighboring voxels 
with intensities over a predetermined intensity threshold. The intensity threshold was set 
as the 20th percentile of all intensities of the seed voxels. Bubbles in the segmentation 
caused by low intensity slow moving or recirculating blood were filled using connected 
component analysis [17]. Small holes at the edges of the segmentation were filled by 
iterative reclassification. In three iterations, hole voxels were filled when they were 
surrounded by arterial voxels within 8 voxel steps along rays in 24 of 26 directions [12]. 
Finally connected component bubble filling was repeated.  
Human source images for hypertension tortuosity study 
 The hypertensive subjects were drawn from two populations. Twenty 
hypertensive subjects were identified by measurement of blood pressure at the 
Neuroscience Research Institute (NRI), Gachon University of Medicine and Science in 





under approval from the Gachon University institutional review board and the Korean 
Food and Drug Administration. 
 For the second population, MRA images were selected from existing brain MRA 
images acquired from clinical hypertensive patients between 2008 and 2010 at the 
University of Utah Medical Center. The selection of subjects and the retrospective study 
of previously acquired images were performed with approval from the University of Utah 
institutional review board. All the Utah hypertensives (N =21) had a history of 
hypertension in the medical record demonstrating that they were under the care of a 
physician, making this a controlled hypertensive population. Diagnoses commonly 
associated with hypertension were allowed in the Utah hypertensive case population 
including transient ischemic attack, ischemic stroke, arterial disease, heart disease, sleep 
apnea and atrial fibrillation. Other diseases that may independently affect vasculature 
were excluded from the Utah hypertensive case population. These were diabetes, cancer 
[18], intracranial aneurysm, and genetic syndromes: hereditary hemorrhagic 
telangiectasia, Marfan syndrome and Loeys-Dietz syndrome [19, 20]. The Utah negative 
control population was collected with IRB approval from clinical brain MRA images 
acquired from 2008 to 2010 (N = 45). The Utah negative control population had the 
following traits: subjects with headache, trigeminal neuralgia or head trauma; available 
brain MRA head images; no vascular pathology recorded in the radiology report; and no 






 A third negative control population was obtained from a study on healthy aging 
conducted in North Carolina, U.S.A. [21]. Vascular and psychological diseases were 
screened out in this sample.  
MRI scanners 
 The data were acquired on different MRI scanners. The NRI data set was acquired 
with a 7.0 T MRI scanner (Magnetom, Siemens Medical Systems, Erlangen, Germany) 
[22, 23]. The North Carolina data were acquired with a 3.0 T MRI scanner (Allegra, 
Siemens Medical Systems). The Utah images were clinical scans from both 1.5 T (GE) 
and 3.0 T (Siemens) MRI scanners at a range of image resolutions. 
Arteries measured 
 The arteries measured, the start and end points of the centerlines considered, and 
the points along the tortuosity curve selected for tortuosity measurement are described in 
Table 3.1. Examples of artery selection are shown in Figure 3.4. The measurements for 
the lenticulostriate arteries (LSA) were for the left-most, right–most, and a mean of up to 
four prominent LSAs. Figure 3.5 demonstrates the tortuosity curves created for an 
internal carotid artery (ICA) with the DFM measurement taken from the peaks of the 
curves (Figure 3.5 top) and the left anterior cerebral artery (ACA) – anterior 
communicating artery (Acom)– right ACA (Figure 3.5 bottom) measurement taken from 





Filtering the images 
 The NRI data required filtering before segmentation. The image data were median 
filtered; then the filtered image was subtracted from the original image. The arteries were 
segmented from the subtracted image. The effect of filtering on tortuosity was tested by 
measuring tortuosity of the Korean hypertensive population treated with different filters: 
no median filter, 5x5 median filter and an 11x11 median filter. After the comparison the 
5x5 median filter was selected and used for treating the NRI data before segmentation. 
An exception was made where no filtering step used on segmentations used for 
measuring the small LSAs.  
Resolution and interpolation 
 The images were acquired at several different resolutions. Lower resolution 
images were sinc interpolated to higher resolutions [24]. For each subject in the NRI 
population, two MRA data sets were acquired: a thicker resolution (low 0.8x0.8x0.8 mm) 
set and a thinner and higher resolution (0.23x0.23x0.36 mm) set. The lower resolution 
data were interpolated to resolutions of 0.4x0.4x0.4 mm and 0.2x0.2x 0.2mm. The 
clinical Utah data were acquired from 0.38x0.38x1.6 mm (and interpolated on the 
scanner to 0.19x0.19x0.8) to 0.52x0.52x1.0 mm resolution and the lower resolution 
images were 2X interpolated to higher resolution (0.52x0.52x1.0 to 0.26x0.26x0.5 mm). 






 The effect of resolution and interpolation were measured in the NRI data set by 
measuring tortuosities of the same arteries for the same subjects at 0.4x0.4x0.4 mm, 
0.2x0.2x0.2 mm and 0.23x0.23x0.36 mm resolutions. The 0.4x0.4x0.4 mm, 0.2x0.2x0.2 
mm were interpolated from the same data acquisition and the 0.23x0.23x0.36 mm were 
acquired separately. The ICA arteries are only in the thicker transverse lower resolution 
volume limiting the testing of resolution effects to between the 4X (0.2x0.2x0.2 mm) and 
2X (0.4x0.4x.4 mm) interpolations of the lower resolution image. 
Tortuosity comparisons 
 Arterial tortuosity was measured and compared between different data sets and 
sub sets. Sample data information was stored in a MySQL (http://www.mysql.com/) 
relational database coupled to the R statistical system [25] for visualization and statistical 
analysis. Comparisons were tested with the Wilcoxon rank-sum test. The tortuosity 
comparisons were between: different median filter subtractions of the NRI data, all 
resolutions of NRI data; the three negative controls; males and females; the NRI 
hypertensives and negatives; and Utah hypertensives and negatives. 
Results 
Centerline stability and accuracy 
 Centerline accuracy was measured by comparing the measured centerline with the 





centerlines found with different starting points. The results for the numeric phantoms are 
summarized in Figure 3.6 and Tables 3.2 and 3.3. The multiple branches of the comb 
phantom (Figure 3.1 left) pulled the COM centerline in red below the true centerline in 
green (Figure 3.6 left). The MDFE cost (Figure 3.6 middle) and DFE-COM (Figure 3.6 
right) centerlines overlap (in yellow) more with the true green centerline than the COM 
centerline. 
 Centerline stability as a function of cost function algorithm on brain MRA images 
is summarized in Table 3.4. The DFE-COM was tested on the ICA siphon loop, 
visualized with a white centerline in Figure 3.4 top left, where it loops back upon itself 
often kissing itself and causing problems for centerline extraction. The DFE-COM was 
able to complete as many ICA siphon loops as the COM algorithm with similar stability. 
Tortuosity measurement of phantoms 
 The DFE-COM centerline DFM tortuosity scores were higher for tighter coiled 
helix phantoms with lower pitches and the tortuosity scores increased proportionally to 
the increase in the number of coils (Table 3.5). The pitch 40(2π)-helix has approximately 
one coil (DFM = 2.48) and the pitch 20(2π)-helix has approximately two coils and has 
almost double (ratio = 1.95) the tortuosity score (DFM = 5.45). The tortuosity curves 
were displayed with the distance d (Figure 3.7 top) or length L (Figure 3.7 bottom) on the 





Median filter effect 
 The 7.0 T images were segmented with no suppression of background noise under 
the ZBS segmentation algorithm shown in Figure 3.8, top. Subtracting a median filtered 
image from the images as the first step in the segmentation removed the background 
noise from the segmentation but also removed some of the small lenticulostriate arteries 
while leaving the larger arteries especially in the case of the 5x5 median filter (Figure 3.8 
middle). The larger 11x11 median filter removed most background noise but left some 
noise near the larger arteries while leaving most LSAs in the segmentation (Figure 3.8 
bottom). 
 The median filter subtractions (none, 5x5 and 11x11) had no significant effect on 
tortuosity measurements of left ACA, right ACA, left to right ACA, left ACA and right 
ACA arteries of the hypertensive Korean population at the β = α/n = 0.05/8 = 0.00625 
significance level with a two-sided Wilcoxon rank-sum test. 
Resolution and interpolation effect on tortuosity 
 The tortuosity was measured for the Korean hypertensive and negative control 
populations from the low and high-resolution images. The image volumes were not all 
long enough to capture the ICA accounting for low numbers of ICA measurements. Out 
of the total population size of 40 there were: 19 2X interpolated left ICA, 19 2X 
interpolated right ICA, 21 4X interpolated left ICA and 23 4X interpolated right ICA. 
The tortuosity values were compared with a 2-sided Wilcoxon rank-sum test, and a paired 





high and low interpolations of the same artery. The 4X interpolation had 6.40% higher 
left ICA (P = 0.294, paired P = 0.00042) and 3.65% higher right ICA (P = 0.452, paired P 
= 0.0348) tortuosity than the 2X interpolation (Figure 3.9 top). The mean resolution of 
0.23x0.23x0.36 mm (mean 0.273 mm) is closer to 0.2x0.2x0.2 mm (0.0733 mm 
difference) than 0.4x0.4x0.4 mm (0.127 mm difference). The mean DFM taken from the 
tortuosity curves of the left ACA, right ACA and left to right ACA of the 0.23x0.23x0.36 
mm images was 6.89±2.45% greater than the 0.4x0.4x0.4 mm images of the same 
subjects. The 0.2x0.2x0.2 mm images actually had 3.05±1.89% lower tortuosity than the 
0.23x0.23x0.36 mm images. The difference in magnitude of both mean resolution and 
tortuosity between 0.2x0.2x0.2 mm and 0.23x0.23x0.36 mm images was smaller than 
between the 0.4x0.4x0.4 mm and 0.23x0.23x0.36 mm images (Figure 3.9 bottom). Due to 
increased similarity of scores, only the 0.2x0.2x0.2 mm and 0.23x0.23x0.36 mm were 
used for the hypertensive and negative control comparison experiments later in this study. 
Comparison of negative control populations 
 The Korean negative control population showed significantly less arterial 
tortuosity compared to arteries of the Utah and the North Carolina negative controls 
(Figure 3.10) and the three populations were of similar age (Table 3.6). The Utah and 
North Carolina negative controls did not have significantly different arterial tortuosity. 
ANOVA analysis of the three negative controls: NRI Korean, North Carolina and Utah 
hospital showed significant differences in the left ACA, left to right ACA, left ICA, and 





negative controls with a 2-sided Wilcoxon rank-sum test showed the Korean population 
had significantly lower tortuosity of the left to right ACA, left ICA and right ICA than 
North Carolina and Utah hospital population at the β = 0.01 level. The North Carolina 
and Utah populations did not show any significant differences in arterial tortuosity. 
Female and male comparisons 
 The Utah and North Carolina negative populations were split evenly between 
males and females while the Korean negative population was mostly female. Ethnicity 
was rarely indicated in the Utah medical record but based on the composition of the state 
of Utah, the subjects are most likely white European descent. The North Carolina 
population was mostly of white European descent (Table 3.6). The Korean control was a 
different ethnicity (Asian versus white European descent) and had a greater percentage of 
females. 
 Male and female North Carolina and Utah populations showed no significant 
differences at the β = α/n = 0.05/5 = 0.01 level of 2-sided Wilcoxon rank-sum tests for 
five arteries measured. The lowest P-Value was of the left ICA (P=0.0288) of the North 
Carolina population where tortuosity values for males were higher than for females and 
females had higher tortuosity in three of five arteries measured. There was no significant 
difference in tortuosity between males and females in eight arteries compared at the β = 
α/n = 0.05/8 = 0.0625 level in the Utah negative control (lowest P = 0.0114 with a 1.40% 





 There was no significant difference in arterial tortuosity between males and 
females in our entire current collection of tortuosity measurements at the α = 0.05 level 
(lowest P = 0.342) (Figure 3.11). The collection included the three negative controls, and 
subjects with vascular diseases. The diseases included hypertension, diabetes, cancer, 
stroke, intracranial aneurysm, hereditary hemorrhagic telangiectasia, Marfan syndrome 
and Loeys-Dietz syndrome subjects. There are more females (257) in the collection than 
males (185). The mean ages were similar for females (48.2) and males (46.5).  
Korean hypertension tortuosity comparison 
 The Korean hypertensive population had higher tortuosity across all 13 artery 
measurements than the Korean negative control (Figure 3.12). Ten were significant at the 
α = 0.05 level of the 1-sided Wilcoxon rank sum test. Even with the statistical correction 
of β = α/n = 0.05/13 = 0.0038, 5 of the 13 tortuosity measurements were significantly 
higher in the Korean hypertensive population. The most significant measurements were 
the left ACA (P= 0.00377), the end DFM of left LSAs (P = 0.000161), the end DFM of 
the right LSAs (P = 0.00052), the peak DFM of the left LSAs (P = 0.00977) and the peak 
DFM of the right LSAs (P = 0.00080). There were more prominent LSAs per subject in 







 The Utah hypertensive population (N=21) did not show significant increases in 
tortuosity compared to the Utah hospital negative control (N=45) at the β = α/n = 0.05/8 
= 0.00625 level (Figure 3.13). The test was conducted only against the Utah negative 
control population. Not all images contained measurable arteries for all arteries 
examined. The number of measurements and statistical test results are in Table 3.7. An F-
test of variances showed higher variance of the hypertensive Utah population tortuosity 
than the negative control of the right ICA (P = 0.00206), left VA (P = 0.00093) and right 
VA (P = 0.00174) at the β = 0.00625 level. The hypertensives were insignificantly higher 
in tortuosity of seven of the eight arteries compared. 
Discussion 
 We were able to develop a process of measuring arterial tortuosity including 
segmentation, filtering, interpolation, centerline extraction and DFM tortuosity analysis. 
The DFE-COM centerline was selected for making tortuosity measurements because it 
was able to calculate centerlines around most of the ICA siphon loops in a brain MRA 
data set and had better accuracy in the comb phantom. The subtraction of median filtered 
images from the MRA data had no significant effect on tortuosity and was used when 
necessary to improve artery segmentation. The 5x5 median filter was selected when 
measuring tortuosity of arteries other than the LSAs in the NRI data for the filter's ability 
to remove more fully background noise and process images faster than the larger filter 





chance of data loss when measuring tortuosity of the LSAs to justify the use of the 
median filter. The DFM tortuosity curve consistently measured the increasing tortuosity 
of the helix phantoms. Interpolating lower resolution images to higher resolution reduced 
the effects of resolution on tortuosity measurement. These results led us to use 
interpolation when comparing tortuosity in hypertensive populations versus negative 
controls. 
 Our methods measured a statistically significant increase in arterial tortuosity in 
the NRI Korean hypertension population compared to the Korean negative control. We 
also observed a dependence of tortuosity measurements upon image resolution. Higher 
resolution images increased the DFM tortuosity scores. Interpolating lower resolution 
images to higher resolutions reduced or eliminated the reduction in tortuosity for lower 
resolutions. Finally different populations may have different baseline tortuosities. 
 Hypertension correlated with increased arterial tortuosity in the Korean 
population study. The consistency across the arteries measured suggests that increased 
arterial tortuosity with hypertension is a systemic phenomenon. Greater change in 
tortuosity was seen in the ICA and LSA arteries than in the ACA measurements. The 
ICAs are longer than the ACAs possibly allowing more twisting due to increased 
hypertension. The LSAs are narrower than the ACAs and small narrow arterioles have 
been shown to twist strongly in response to hypertension [1]. The LSAs also had the 
higher significance of the tortuosity increase. To simplify measuring arterial tortuosity for 






 The correlation between tortuosity and hypertension was not repeated in the Utah 
populations. The Utah hypertensive group was under physician care; therefore many 
patients may have been on antihypertensive medications making this a largely controlled 
hypertensive population. Lack of completeness in the medical records made the number 
of subjects on hypertensive medication difficult to determine. A future experiment could 
compare controlled versus uncontrolled hypertensive (when identified) populations to 
study if antihypertensive medications have an effect on arterial tortuosity. Another 
possibility is that the Utah Hospital negative control is not truly negative. However, the 
Utah Hospital negative control was similar to the North Carolina negative control 
population indicating that the Utah hospital control was negative for increased arterial 
tortuosity and that patients imaged for reasons other than vascular disease reasons are 
usable as negative controls. 
 In a retrospective analysis of images such as this one, universal negative controls 
may not be possible. The Korean population showed significantly lower tortuosity than 
the Utah population. The North Carolina negative control was similar to the Utah hospital 
population in tortuosity. The Korean negative control population was mostly female. 
Females in the Utah hospital and North Carolina negative controls and in the entire 
tortuosity collection did not show significantly lower tortuosity than the corresponding 
male populations. The Korean data were higher resolution than the North Carolina or 
Utah data after final interpolations. Any remaining resolution effect on tortuosity would 
increase the Korean data more than the others but they still had the lowest tortuosity of 





white Americans of European descent and the Korean population was all Korean descent. 
Ethnicity remains as one possible cause of the decrease in Korean population tortuosity 
but the negative Korean control tested here was not a broad representation of the Korean 
population. With the ability to interpolate images taken at different resolutions we will 
attempt to obtain more ethnic populations from clinical images to compare arterial 
tortuosity to determine if ethnicity affects arterial tortuosity. 
Conclusions 
 The methods in the study were able to measure a correlation between 
hypertension and arterial tortuosity. The DFE-COM centerline algorithm was able to 
make centerlines for the arteries of interest. The median filter subtraction allowed 
segmentation of the high-resolution data sets without affecting tortuosity. A significant 
increase in arterial tortuosity was measured in the uncontrolled NRI Korean hypertensive 
population versus a corresponding negative control. The Korean hypertensive population 
was not representative of all hypertensive populations or even of all Koreans. No 
significant arterial tortuosity increase was seen in the controlled Utah hypertensive 
population. Therefore we do not know if the increase in tortuosity with hypertension 
occurs in all populations. These methods can be used to study more populations to find 
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ACA anterior cerebral artery 
Acom anterior communicating artery 
COM center of mass 
d distance 
DFE distance from edge 
DFM distance factor metric 
FOV field of view 
HTN hypertensive 
ICA internal carotid artery 
L left 
L length 
LSA lenticulostriate artery 
MDFE modified distance from edge 
MIP maximum intensity projection 
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Figure 3.1. Numeric phantom generation. (left) The comb phantom was made 




Figure 3.2. Phantom helices. 3
faces. (top left) Pitch 5(2π). (top right) Pitch 10(2
(bottom right) Pitch 40(2π).
 
 
-D helix phantoms were display with shaded su










Figure 3.3. High resolution artery segmentation. (top) A high-resolution mag-
netic resonance angiography normotensive image was shown in maximum inten-
sity projection. (bottom) Segmentation of the arteries was shown in shaded sur-
face with colors to highlight bifurcations. 
  
  
Figure 3.4. Selected centerlines. Centerlines of arteries and selections in white 
for tortuosity measurement were shown in maximum intensity projection (MIP). 
(top left) Right ICA was selected in white with progressive distance d in yellow. 
(top right) A lenticulostriate artery (LSA) of a normotensive subject was s
lected. (bottom left) The left to right ACA of a hypertensive patient was selected. 












Figure 3.5. Artery tortuosity curves. Tortuosity curves of one subjects. (top). 
Tortuosity curves of three different subjects ICA arteries. The black curve is 
from Figure 3.4 top left. Tortuosity rises and falls. (bottom). Repeated tortuosity 
curves of the left to right ACA artery of the same subject, from Figure 3.4 bot-






















Figure 3.6. Comb phantom. Comb phantom where green is the true centerline, 
red is the algorithm calculated centerline and yellow is where the true and calcu-
lated centerline overlap. (left). The COM accuracy was displayed. (center) The 






Figure 3.7. Phantom tortuosity curves. Helix phantom tortuosity curves are 
shown in maximum intensity projection. The pitch 5(2π) (black), pitch 10(2π) 
(red), pitch 20(2π) (green) and pitch 40(2π) (blue) phantoms decrease in tortuos-
ity. (top) DFM tortuosity plotted versus distance d from the start. (bottom) DFM 















Figure 3.7 continued.  
  
Figure 3.8. Median filtered segmentations. Median filter 
tions of a 7.0 T NRI image of a hypertensive patient were displayed in maximum 
intensity projection. (top) Segmentation without the median filter subtraction left 
background noise in the segmentation. (center) Segmentation with the 5x5 
dian filter subtraction removed background noise and smaller lenticul
teries (LSA). (bottom) Segmentation with the 11x11 median
















Figure 3.9. Tortuosity and resolution. Comparison of mean tortuosity of the same 
Korean subjects from NRI with one standard deviation error bars. (top) Left and 
right ICA tortuosity measurements from higher 0.2x0.2x0.2 mm (0.2 mm) resolu-
tions interpolations of the same images increased compared to 0.4x0.4x0.4 mm 
(0.4 mm) resolution. (bottom) The mean DFM tortuosity of the 0.2x0.2x0.2 mm 
(0.2) and 0.23x0.23x0.36 mm (0.23) resolution images were closer together than 




















Figure 3.10. Negative control tortuosities. Utah and North Carolina negative 
(NEG) controls had significantly higher tortuosity than the NRI Korean negative 






















Figure 3.11. Female-male tortuosity. Mean arterial tortuosity comparison with 1 
standard deviation error bars between female and male subjects showed no sig-





















Figure 3.12. NRI Korean tortuosities. NRI Korean negative versus hypertensive 
(HTN) arterial mean tortuosity comparisons with 1 standard deviation error bars. 
LSA 1 left was the left most LSA and LSA 1 right was the right most LSA. (top) 
The figure showed the mean end DFM tortuosity measures. (bottom) The figure 








































Figure 3.13. Utah hypertensive tortuosity. Comparison of Utah common hyper-
tension (HTN) and Utah hospital negative (NEG) control with 1 standard devia-





















Table 3.1. Tortuosity curve measurement point 
Artery Start End Measurement 
Left ACA Left ICA/ACA 
bifurcation 
Acom End to end 
Right ACA Right ICA/ACA 
bifurcation 
Acom End to end 
Left ACA - Acom 





End to end 
Basilar Posterior cerebrals Vertebral arteries End to end 




Bottom of slab Peak 
Left and Right VA Basilar artery Bottom of slab Peak 
LSA (7 T images) MCA Visible end Peak and end-end 
The measurement for each artery is taken from different points on the tortuosity 
curve of the anterior cerebral artery (ACA), internal carotid artery (ICA), ante-
rior communicating (Acom), vertebral artery (VA), basilar arteries and lenticu-
lostriate artery (LSA). Middle cerebral artery (MCA) bifurcations are used a 
starting points for some measurements. 
Table 3.2. Comparison of algorithm stability and accuracy of comb phantom 
Algorithm Number of trees Stability RMSE of Accuracy 
COM 6 0.918 0.879 
MDFE 6 0.819 0.417 
DFE-COM 6 0.905 0.413 
The COM cost function shortest paths centerline algorithm was less accurate in 






Table 3.3. Comparison of algorithm stability and accuracy on 3 branch phantom 
Phantom noise Algorithm Number 
of trees 
Stability RMSE of Accuracy 
SD-10 COM 3 0.960 0.463 
SD-10 MDFE 3 0.930 0.393 
SD-10 DFE-COM 3 1.00 0.556 
SD-20 COM 3 0.950 0.528 
SD-20 MDFE 3 0.946 0.674 
SD-20 DFE-COM 3 0.955 0.561 
The DFE-COM cost function shortest paths centerline algorithm had similar sta-
bility and accuracy to the COM based centerline algorithm. The MDFE cost algo-





























































































































COM 15/16 0.938 7/8 0.875 37.000 12.352 0.872 0.0459 
MDFE 7/16 0.438 1/8 0.125 39.875 13.228 0.673 0.0732 
DFE-
COM 
15/16 0.938 7/8 0.875 38.625 11.439 0.825 0.0434 
The COM and DFE-COM cost function shortest paths centerline algorithms cal-






Table 3.5. Helix phantom tortuosity 




Peak DFM/2.80 ratio 
Pitch 5(2π) 20.95 8 7.48 
Pitch 10(2π) 10.76 4 3.84 
Pitch 20(2π) 5.45 2 1.95 
Pitch 40(2π) 2.80 1 1.00 
The peak distance factor metric tortuosity scores are lower with increasing pitch 
of the three-dimensional helix phantoms. 
Table 3.6. Negative control demographics 






White Asian Black 
NRI Korean 20 47.7 3(15.0) 17 (85.0) 0 (0.00) 20 (100.0) 0 (0.00) 
North Carolina 95 42.7 45 (47.4) 50 (52.6) 83 (87.4) 8 (8.4) 4 (4.2) 
Utah 45 46.7 23 (51.1) 22 (48.9) - - - 
The Korean negative control population was mostly female whereas the North-
Carolina and Utah negative control populations where evenly split between fe-















Left ACA 43 21 0.0565 +0.232 
Right ACA 39 21 0.279 -0.0824 
Basilar 42 18 0.0641 +0.0302 
L to R 
ACA 
24 11 0.805 +0.501 
Left ICA 35 19 0.132 +0.371 
Right ICA 36 19 0.366 +0.00206 
Left VA 36 18 0.283 +0.00093 
Right VA 35 16 0.297 +0.00174 
A (+) indicates increased hypertensive tortuosity and a (-) indicates decreased 
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 High arterial tortuosity may signify early arterial pathology which may precede 
development of intracranial aneurysms. We measured arterial tortuosity of intracranial 
vessels and reviewed the medical records of three groups of patients: with intracranial 
aneurysms, without aneurysms but at increased clinical risk, and controls without 
aneurysms or associated risk factors. There was significant but inconsistent evidence of 
increased arterial tortuosity in aneurysm cases and high-risk cases across different 
arteries. Medical records review identified that a subset of aneurysm cases carried a 
diagnosis of Loeys-Dietz syndrome that is often misdiagnosed as Marfan syndrome. We 
found increased arterial tortuosity in the Loeys-Dietz syndrome cases. A combination of 
medical record screening for Marfan syndrome or Loeys-Dietz symptoms such as 
aneurysms and evaluation of arterial tortuosity by a curve of scores from medical images 
may identify previously undiagnosed cases of Loeys-Dietz syndrome. 
Key words: Aneurysm, MRA, Loeys-Dietz, tortuosity. 
Introduction 
 There are autopsy reports of increased arterial and arteriolar tortuosity in aged 
subjects with hypertension and aneurysms1. While hypertension is considered a risk 
factor for developing intracranial aneurysms, the clinical importance of the greater 
arteriolar tortuosity noted on autopsy2,3, to the development of intracranial aneurysms is 
not clear. The small arterioles visible on dissection at autopsy are not readily visible 





Angiography (TOF-MRA) imaging has been used to assess arterial tortuosity of larger 
vessels. Increased tortuosity of arteries visible in MRA has been shown to correlate with 
aging4, exercise level5, tumors6, retinal pathology7 and certain genetic syndromes8,9. The 
degree of arterial tortuosity can be quantitatively measured from MRA images with the 
Distance Factor Metric (DFM) tortuosity score that is calculated by measuring the length 
(L) along the centerline of the artery divided by the straight line distance (d) from two 
points10-13. In the conventional use of DFM, only two points are selected per artery, 
producing a single tortuosity score or zero-dimensional measure of tortuosity (DFM0) for 
the artery. Whether used for intersubject or intrasubject measurements, DFM0 is 
constrained by the underlying data: images may not consistently contain the same two 
well defined points along the artery, images may contain different lengths of the artery, 
and the tortuosity may be sensitively dependent upon the selection of the two points. This 
study expands the conventional use of DFM to create a one dimensional tortuosity score 
curve (DFMc) displaying local tortuosity information along a vessel. The DFMc is then 
used to assess the relationship between arterial tortuosity of larger vessels seen in TOF-
MRA with the development of intracranial aneurysms. 
 This study utilized medical imaging to assess the degree of arterial tortuosity 
noted in patients with a clinical history of aneurysm, or predisposition to aneurysm14-16, 
recorded in the medical record. We were specifically interested in determining whether or 
not patients with familial aneurysms, nonfamilial aneurysms or in high-risk subjects 





Materials and methods 
Source images 
 All TOF-MRA images were collected from the University of Utah Medical Center 
in Salt Lake City, UT, U.S.A. with approval from the University of Utah Institutional 
Review Board. A negative control population was collected retrospectively from clinical 
TOF-MRA head images taken within the last three years. The negative control population 
included patients with a diagnosis of headache or trigeminal neuralgia who underwent 
TOF-MRA head imaging but in whom no vascular disease (aneurysmal dilation or 
stenosis) was identified in the radiology report and in whom no risk factors for vascular 
disease were noted in the medical record (including: arterial disease, atrial fibrillation, 
diabetes, hypertension, and acquired heart disease). The control group also had cancer or 
genetic syndromes screened out. The high-risk group and aneurysm group were 
comprised of cases previously identified in a study on high (two-fold) familial risk of 
intracranial aneurysms14 and from patients treated for aneurysms at the University of 
Utah Medical Center. The images were clinical scans at a range of resolutions. Lower 
resolution images were interpolated to higher resolution with a sinc interpolation for 
comparison to higher resolution images. 
Arterial tortuosity measurement summary 
 The arterial tortuosity measures were made by segmenting the arteries from the 
background, generating a centerline through the segmentation and selecting two end 





tortuosity score is calculated by measuring L along the centerline of the artery divided by 
d from the starting point10-13. Rather than compute a single DFM tortuosity score per 
artery (DFM0), the L/d tortuosity was calculated at every point on the centerline with 
respect to the starting point to create a one-dimensional tortuosity score curve (DFMc). A 
tortuosity measure based upon a smoothed centerline was also calculated by averaging 
the position of each centerline point with its two adjacent neighbors to compute a 
smoothed version of L (Ls) and the smoothed tortuosity score, DFMcs = Ls/d. After 
computing the DFMc curve, an optimal point along each artery was selected for reporting 
DFM. In this study, the final DFM tortuosity scores were taken as either the peak DFM 
value of the DFMc curve or the end DFM value of the DFMc curve when the arterial 
centerline left the image volume and no defined second end existed. 
Tools 
 The segmentation and tortuosity measurement tools were implemented as ImageJ 
plugins17-19. The measured centerline positions and subject information were stored in a 
MySQL relational database available at http://www.mysql.com/. Plotting of tortuosity 
score curves, box and whiskers plot comparisons, and statistical tests were conducted 
with R20, connected directly to MySQL using MySQL Open Database Connectivity 






 Statistical significance was set at the α = 0.05 level and Bonferroni corrected to β 
= α/n, where n is the number of tests in a set. The significance level was adjusted instead 
of the P-value of statistical tests to show raw test results. The Wilcoxon rank sum test 
was used throughout the study as it does not require normality of the underlying 
populations and is resistant to outliers. F-test and T-test were used with larger sample set 
sizes where normality can be assumed by the central limit theorem. The F-test tested for 
differences in variation of tortuosity scores and the T-test was used to confirm the 
Wilcoxon rank sum test results. 
Segmentation 
 The TOF-MRA images (Figure 4.1) were segmented using a Maximum Intensity 
Projection (MIP) Z-buffer segmentation22(Figure 4.2). 
Centerlines 
 The centerlines were generated from the segmentations using a centerline 
algorithm based on algorithms previously described23,24 with a cost function modification 
where the Center of Mass (COM) voxel costs were multiplied by the Distance From Edge 
(DFE) values of the voxels to give higher weights to voxels at the center of the 
segmented arteries. Due to the limitations of intensity based segmentation, the internal 





during centerline extraction. The ability of the centerline algorithm employed here to 
extract the proper geometry of the internal carotid artery was validated using the 
centerline stability metric previously developed24. 
Artery selection and tortuosity measurement 
 Arteries were selected for tortuosity measurement by first selecting two end-
points of a centerline through the segmentation of the desired artery. Unlike a traditional 
DFM0 measurement, in this case it was only necessary that one of the two end-points be a 
common anatomical location for each measured artery, generally a bifurcation shared by 
all subjects. The second end-point could either be another common anatomical location 
or the point at which the artery of interest exited the image volume. The three-
dimensional segmented artery image was colored to assist the user in selecting centerline 
segments for tortuosity measurement. The red centerlines connect at the bifurcations 
which are indicated by green dots (Figure 4.3). A separate random color was assigned to 
each centerline to cause a color change at the bifurcations to aid the user when locating 
bifurcations.  
Visual correlation 
 The quantitative DFM tortuosity scores were correlated to visual tortuosity 
rankings. A total of 315 subjects including negative controls and vascular disease cases 





based tortuosity score at the end of the basilar artery where it bifurcates into the left and 
right vertebral arteries (Figure 4.4). Every 11th subject beginning with the subject with the 
highest tortuosity score was selected to obtain a subset of 25 subjects with a wide range 
of arterial tortuosities. For each of the 25 subjects, MIP images were computed in the 
transverse plane with 18 rotations taken every 10 degrees (MIP images at 180 degrees 
difference are the same) showing the entire brain vasculature imaged. These images were 
shown to a group of five volunteer medical imaging researchers who ranked the basilar 
arteries highest (rank 1) to lowest (rank 25) in tortuosity. The volunteers were advised to 
compare images pairwise and were given no time limit or consistency training to avoid 
bias25. The means of the human rankings were compared by Spearman rank correlation to 
the rank determined by the quantitative end of artery DFMc and DFMcs scores of the 
basilar artery. 
 Tortuosity was measured for multiple arteries in the image slabs. The arteries 
measured were the left and right anterior cerebral arteries (ACA), across the left ACA 
through the anterior communicating artery (Acomm) to the right ACA; the basilar artery, 
the left and right internal carotid arteries (ICA) from the ICA bifurcation with the middle 
cerebral artery (MCA) and ACA to the lower end of the image slab, and the left and right 
vertebral arteries from the bifurcation with the basilar artery to the lower end of the 
image slab. The tortuosity score was taken from the tortuosity score curve at the end of 
the curve for the basilar, anterior cerebral artery (ACA) and ACA-anterior 
communicating artery (AComm)-ACA measurements. The tortuosity score was taken at 





measurements because the end of these arteries varied depending on the depth of the 
image slabs. 
Results 
 The end DFMc had higher correlation to the mean visual rankings than the 
smoothed end DFMcs tortuosity score. The end DFMc had a 0.72 Spearmen rank 
correlation coefficient (P < 0.0001) (Figure 4.5) with the mean visual ranking while the 
end DFMcs correlation was 0.67 (P = 0.00025). The mean of the correlation between all 
pairs of human visual ranks was 0.88±0.048. Both the end DFMc and end DFMcs 
quantitative tortuosity scores were calculated and used in statistical tests of differences 
between the test cases and negative controls. Only the end DFMc scores are reported due 
to better correlation with the mean visual ranks and due to the fact that the results of the 
tests differed little with the two measurements. 
 We measured the arterial tortuosity of eight arteries between the intracranial 
aneurysm group and the negative control population. The difference in tortuosity was 
tested at the β = α/n = 0.05/8 = 0.00625 level to account for testing eight arteries. Only 
the left ACA tortuosity measurement was noted to be significantly greater in the 
aneurysm cohort (indicated in bold in Table 1). While the aneurysm group had greater 
tortuosity in all eight arteries (indicated with a + in the “Difference of means” column in 
Table 4.1), the difference from the control group was not statistically significant for the 
other seven arteries. The aneurysm cases also had significantly higher variance in right 





approximately eight years older than the negative control group. As the data set was 
obtained from existing images taken for other purposes, the images often included 
different arteries and in some instances image quality prevented measurement of some 
arteries resulting in different number (N) of measurements for each artery recorded in 
Table 4.1. 
 The negative controls who were < 40 or > 55 years produced no statistically 
significant differences at β = 0.00625 with the 1-sided Wilcoxon signed rank test (used 
exclusively due to the small sample size) across the eight arteries. Three arteries had 
higher tortuosity in the > 55 population (+) and five arteries had higher tortuosity in the < 
40 population (-) (Table 4.2). 
 The familial aneurysm cases had significantly higher tortuosity of the left ACA 
than the negative controls at the β = 0.00625 level. Eight of the eight arteries had higher 
arterial tortuosity (+) in the familial aneurysm cases than the negative controls but seven 
were not significant (Table 4.3).  
 A manual medical record chart review of the highest scoring tortuosity measures 
of intracranial aneurysms cases revealed one diagnosis of Marfan syndrome (without 
genetic confirmation), two of Loeys-Dietz syndrome (LDS) (with genetic confirmation) 
and eight high familial risk intracranial aneurysm (IA) cases. Before 2005 LDS cases 
were often diagnosed with Marfan syndrome making diagnosis without genetic 
confirmation ambiguous. Further chart review demonstrated that the one patient 
diagnosed with Marfan syndrome did not meet clinical criteria for this diagnosis raising 





 Additional LDS cases were collected to test for an increase in arterial tortuosity in 
LDS patients. Six syndromic cases including five genetically confirmed Loeys-Dietz 
syndrome (LDS) and the one unconfirmed clinical Marfan diagnosis had significantly 
greater tortuosity of the basilar and the left VA at the β = 0.00625 level (Table 4.4). 
Examples of tortuous vertebral arteries of Loeys-Dietz patients are shown in Figure 4.6 
and Figure 4.7. For comparison Figure 4.8 shows a low tortuosity VA and Figure 4.9 
shows the tortuosity curves of those arteries. These patients had greater tortuosity of eight 
of eight arteries measured. Two of the confirmed LDS patients and the one unconfirmed 
clinical Marfan syndrome cases had intracranial aneurysms and the other three confirmed 
LDS cases did not have aneurysms. 
 Patients with nonfamilial aneurysms and without an underlying genetic syndrome 
had significantly greater left ACA arterial tortuosity by t-test than negative controls. 
Tortuosity measures were greater in seven of eight arteries. Nonfamilial aneurysm cases 
also had significantly higher variation in the left and right ICAs (Table 4.5). 
High intracranial aneurysm risk family case subjects without aneurysms themselves had 
significantly higher arterial tortuosity in the left ICA and significantly higher variance in 
the left VA. These case subjects had higher tortuosity in seven of the eight arteries 
measured (Table 4.6). 
Discussion 
 Measurement of arterial tortuosity is a newly developed technique that may prove 





curve and associated peak and end measurements described herein appear to provide 
more information than the traditional single value DFM0 tortuosity score. By selecting 
the peak tortuosity score from a curve of values defined from a single end-point, we 
obtain a meaningful tortuosity value from arteries with only one well-defined end-point 
in a medical image. The original DFM0 method required selection of the same two 
defined end-points for all arteries to be compared, making it unusable when there was 
only one defined point as is often the case with the long ICA and vertebral arteries. 
Furthermore, analysis of the DFMc tortuosity score curves shows that the tortuosity score 
may vary significantly along the vessel as indicated in Figure 4.9. Thus, by considering 
only two particular end-points per artery, the traditional tortuosity analysis may both 
greatly underestimate the peak value and be sensitively dependent on end-point selection.  
 Using the methods described herein, we have been able to demonstrate a 
significantly greater degree of arterial tortuosity in patients with connective tissue 
syndromes who are known to be at risk for intracranial aneurysms8,27. Nonsyndromic 
patients with intracranial aneurysms, subjects with high familial risk of intracranial 
aneurysms, relatives of high-risk aneurysm cases, and patients with nonfamilial 
aneurysms had inconsistently higher arterial tortuosity than negative controls. The 
overlap in tortuosity scores between high familial risk intracranial aneurysm cases with 
negative controls indicates high-risk subjects with normal tortuosity scores can develop 
intracranial aneurysms. There was also no significant difference between high-risk 





tortuosity in patients with Loeys-Dietz syndrome, a disorder associated with the presence 
of intracranial aneurysms, was significantly different than in negative controls. 
 Age has been shown to mildly increase tortuosity in healthy populations4. The age 
comparisons conducted here showed no significant tortuosity increase due to age. It is 
thus unlikely that the age difference between the aneurysm and negative control 
populations accounted for the differences in tortuosity. 
 The human visual rankings correlation to each other was closer than to the 
quantitative tortuosity score based ranks. This phenomenon of humans correlating with 
each other better than a computer score has been previously described25. The human 
rankers may be using information seen in the surrounding image, or alternatively there 
could be a bias in the projections shown to the rankers causing their ranks to cluster 
together. 
 The results of this study provide evidence that tortuosity measurements may be 
able to assist in characterizing specific nonnormal states and may even assist in 
distinguishing between patients with Loeys-Dietz syndrome and Marfan syndrome. 
Loeys-Dietz syndrome is a more aggressive disorder associated with visible arterial 
tortuosity and aneurysms throughout the arterial tree8,27 where many but not all affected 
patients will go on to develop cerebral aneurysms. In light of the fact that Loeys-Dietz 
syndrome was only determined to be a unique clinical entity apart from Marfan syndrome 
within the last decade28, many affected patients may still carry the diagnosis of Marfan 
syndrome. Marfan syndrome is caused by a mutation in the FBN1 gene that encodes for 





imaging of the ascending aorta as the remainder of the arterial vessels are not thought to 
be at significant risk of aneurysm formation. In contrast, Loeys-Dietz syndrome is caused 
by mutations in the TGFBRI and TGFBRII genes which encode for receptors for the 
cytokine TGF-β27,28. By collecting and measuring arterial tortuosity data in patients with 
either clinical diagnosis we hope to be able to distinguish between the two disorders and 
determine which patients with Loeys-Dietz syndrome are at greatest risk for cerebral 
aneurysm formation. Initial review of arterial tortuosity in Loeys-Dietz patients 
demonstrated that these patients may have the greatest increase in tortuosity in the extra-
cranial vertebral arteries which are typically more caudal than the sections analyzed in 
this study. Assessment of both the cervicocephalic vessels and intracranial vessels may 
prove valuable 30. 
 This study demonstrates the potential to combine medical record screening with 
automated image analysis to screen patient data. The study started with familial and 
nonfamilial intracranial aneurysm cases and discovered the syndromic patients during the 
course of the research. The method for measuring arterial tortuosity is now semi-
automated. Future development will further automate the tortuosity measurement. 
Automated medical record screening systems already exist. In this case the two methods 
of medical record and image screening could be combined to look for patients with 
diagnosis of Marfan syndrome or other Loeys-Dietz symptoms and high arterial 
tortuosity to identify undiagnosed Loeys-Dietz patients in electronic medical records. 
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Figure 4.2. Segmented arteries from TOF
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Figure 4.4. Histogram of basilar artery end DFM
scores. 
 




Figure 4.5. Comparison of mean visual rank (x
DFMc tortuosity score (y-axis) of the basilar artery with regression line (0.72 
Spearmen rank correlation coefficient).
 
 






Figure 4.6. Distance Factor Metric 
scores of the left vertebral artery of a suspected Loeys
white. Yellow lines show d
left vertebral artery tortuosity of the aneurysm 
Figure 4.7. Loeys-Dietz syndrome intracranial aneurysm subject with median to
tuosity among aneurysm case subjects of the left vertebral artery and high tort
osity of the basilar artery. Gre
Figure 4.8. Nonfamilial intracranial aneurysm subject with low tortuosity left 
vertebral artery. Red line in Figure 4.9.
 
 
(DFM) = Length (L) / distance (d) tortuosity 
-Dietz patient selected in 
 and progressive steps. This subject had the maximum 
subjects. Black line in Figure 4.9.
 












Figure 4.9. Vertebral artery tortuosity score curves of the highest peak tortuosity 
score (black line), median tortuosity score (green line) and low tortuosity score 
(red line). The peak score is taken between the dotted lines to avoid small varia-
tions causing spikes when the lengths L and d are short and subject to noise and 


































































































































































































































































































































































































































































































































































































End 16 1.379±0.120 27.938 16 1.368±0.106 65.562 -0.80 0.566 
Right 
ACA 
End 16 1.449±0.142 27.938 15 1.435±0.148 64.333 -1.0 0.727 
L-R 
ACA 
End 12 1.699±0.150 26.000 6 1.708±0.223 68.000 +0.51 0.625 
Basilar End 16 1.176±0.089 27.938 15 1.166±0.075 65.867 -0.88 0.673 
Left 
ICA 
Peak 12 2.796±0.556 28.250 14 3.438±0.699 66.500 +23.0 0.013 
Right 
ICA 
Peak 13 2.849±0.380 28.000 14 3.010±0.534 64.857 +5.7 0.229 
Left 
VA 
Peak 14 1.339±0.154 28.357 13 1.318±0.104 64.615 -0.46 0.215 
Right 
VA 







































































Left ACA 23 1.474±0.127 58.610 +7.2 0.00063 
Right ACA 22 1.535±0.136 56.250 +5.8 0.019 
L-R ACA 12 1.708±0.168 55.067 +0.82 0.389 
Basilar 18 1.217±0.096 57.571 +1.8 0.183 
Left ICA 20 3.345±0.685 59.654 +6.0 0.220 
Right ICA 20 3.171±0.843 58.568 +7.8 0.268 
Left VA 21 1.432±0.234 58.603 +6.1 0.087 

































































Left ACA 5 1.407±0.168 19.200 +2.3 0.474 
Right ACA 4 1.704±0.448 20.000 +17.5 0.131 
L-R ACA 4 2.143±0.709 20.000 +26.5 0.063 
Basilar 5 1.443±0.300 25.300 +20.6 0.0045 
Left ICA 3 3.361±0.388 26.833 +6.5 0.323 
Right ICA 3 3.263±0.688 26.833 +10.9 0.216 
Left VA 6 1.931±0.652 23.750 +43.1 0.00043 
























































































Left ACA 42 1.454±0.150 54.751 +5.7 0.0069 0.047 0.0036 
Right ACA 44 1.471±0.167 54.953 +1.4 0.330 0.193 0.270 
L-R ACA 19 1.725±0.202 54.596 +1.8 0.310 0.526 0.303 
Basilar 38 1.207±0.107 55.789 +0.89 0.328 0.360 0.318 
Left ICA 34 3.577±1.262 54.710 +13.3 0.165 0.0024 0.049 
Right ICA 30 3.450±1.216 56.703 +17.3 0.059 <0.0001 0.020 
Left VA 27 1.395±0.155 54.333 +3.3 0.105 0.980 0.128 



















































































Left ACA 53 1.423±0.111 46.604 +3.5 0.012 0.921 0.019 
Right ACA 52 1.494±0.131 46.577 +3.0 0.076 0.805 0.061 
L-R ACA 25 1.706±0.149 50.000 +0.68 0.241 0.421 0.403 
Basilar 31 1.182±0.082 47.387 -1.2 0.724 0.490 0.724 
Left ICA 37 3.850±1.053 46.405 +21.9 0.0023 0.039 0.00092 
Right ICA 36 3.330±0.781 45.639 +13.2 0.028 0.019 0.0079 
Left VA 47 1.423±0.254 48.234 +5.4 0.087 0.0030 0.054 
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Developing the use of arterial tortuosity 
 Arterial tortuosity has been associated with a limited number of vascular diseases 
and is used clinically in only in limited diseases. As described in the introduction visual 
tortuosity is used to assist in diagnosing LDS and quantitative tortuosity is used in 
diagnosing retinal diseases. Other vascular diseases have been associated with increased 
arterial tortuosity but are not used clinically due to lack of evidence of associations and 
clinical tools to quantitatively measure arterial tortuosity.  
 This research developed a system for measuring and comparing arterial tortuosity 
between populations. The system was able to detect increases in arterial tortuosity in a 
hypertensive population and in clinical images of LDS patients versus negative controls. 
While the measure detects differences at the population level the means of the Korean 
hypertensive and LDS samples fell within one standard deviation of the corresponding 
negative controls. This prevents the measure from differentiating individual clinical 
samples. The ability to detect the population differences demonstrates the ability of the 
tortuosity measurement system to measure increases in tortuosity at the population level 
since there is no gold standard to compare against for arterial tortuosity measurements. 





increased arterial tortuosity in those populations. Due to limited sample size and diversity 
more samples of both hypertensives and LDS patients are needed to confirm the increases 
in arterial tortuosity associated with these diseases. The tortuosity measurement system 
developed here can be used for future studies on more hypertensive, LDS and other 
disease populations.  
Validation of arterial tortuosity measurement 
 The tortuosity measure combining the DFE-COM based centerline algorithm and 
DFM tortuosity curve was able to detect tortuosity differences in a prospective 
hypertensive population and in the clinical LDS population demonstrating the methods 
ability. There is no gold standard for measuring arterial tortuosity. As demonstrated in the 
visual tortuosity ranking experiment in Chapter 4, visual tortuosity scoring has intra-
ranker variability (0.88±0.048 Spearman rank coefficient). A repeat of the ranking 
experiment with neurosurgeons had a lower 0.65±0.13 Spearman rank coefficient 
between rankers demonstrating the instability of visual tortuosity scoring. As mentioned 
earlier the SOAM measurement detected changes due to aging while the ICM did not [1] 
and ICM measurement detected changes due to exercise while the SOAM did not [2]. 
There is no single gold standard way to measure tortuosity in all situations. The tortuosity 
measurement method used depends on the disease. 
 LDS patient tortuosity is characterized by type I tortuosity with long gently 
curving arteries without abrupt changes in slope of the centerline. The DFM 





derivative tortuosity measure was designed to detect abrupt changes in slope of the 
centerline making it less than ideal for detecting the type I tortuosity displayed in LDS 
patients. The DFE-COM based centerline DFM tortuosity curve measurement used here 
was able to detect increased tortuosity in LDS patients. 
 Which type of tortuosity is displayed by hypertensives was less clear, but the 
DFE-COM based centerline DFM curve consistently measured arterial tortuosity across 
several arteries. Additional measurement methods were not needed. Other diseases that 
cause abrupt changes in direction of the centerline may require different tortuosity 
detection methods. 
 The hypertension study was able to make quantitative measurements of the 
smaller LSA arteries due to the use of 7.0 T MRA and the ability of the ZBS algorithm 
[4, 5] to segment the LSAs. Segmentation of arteries is a difficult ongoing area of 
research [6]. Therefore the hypertension study pushed down the lower diameter limit of 
what arteries can be measured from MRA images in living patients. Hypertension 
showed greater change in tortuosity of the narrow diameter LSAs than other larger 
diameter arteries. Smaller diameter arteries may increase (or decrease) in response to 
disease progression or treatment sooner than larger diameter arteries. Thus tortuosity 






Quantitative image phenotype measurement of genotype 
 The tortuosity measurement of LDS patients is a quantitative measurement of the 
phenotypic effect of the LDS genotype. LDS can be caused by mutations in at least two 
different genes, TGFBR1 and TGFBR2 and there are multiple mutations within those 
genes [7-9]. The different mutations may have different levels of effect [10] that may be 
quantifiable by the tortuosity measurement. Quantitative measurement of arterial 
tortuosity could also be used to identify the presence of genetic modifiers that are 
secondary genes that alter the phenotypic expression of the primary mutations. Genetic 
modifiers are thought to explain the range of severity of MFS [11]. Quantitative 
phenotype measurement is also important for epigenetics research into how 
environmental factors alter genotypes expression [12]. Epigenetic research studies the 
changes in gene expression (phenotype) not due to changes in DNA [13]. Quantitation is 
important when attributing part of a phenotype to genotype and part to environmental 
factors or an interaction of the two [12]. 
Flexible analysis system 
 The tortuosity measurement and group comparison system developed stored data 
for reanalysis with new algorithms. The system included a relational database for storing 
data such as the centerline voxel positions and subject information. Tortuosity 
measurements were calculated on the fly for comparison between groups. This allowed 
reanalysis of the data with different algorithms. The intracranial aneurysm analysis tried 





storing of the centerline points allows for future development of smoothing algorithms on 
the centerlines. Calculation of tortuosity on the fly allows new tortuosity measurement 
algorithms as necessary. This tortuosity measurement system also handles measurement 
of many different arteries. The system was first developed on the basilar, anterior 
cerebral arteries (ACA), internal carotid arteries (ICA) and vertebral arteries (VA). Then 
the study on hypertension added the lenticulostriate arteries (LSA) and the system was 
able to detect an increase in LSA tortuosity in a hypertensive population compared to the 
corresponding negative control. The system was designed for reanalysis accumulated 
data, newly added data and new arteries with the same or new analysis methods. 
 The data storage and on the fly tortuosity measurement were important for 
analysis of existing data and new clinical data. The database enabled reanalysis when 
new subject data were added to existing diagnosis groups. The storage of diagnostic and 
demographic data makes creation of new groups to answer questions that arise from 
previous experiments simple. An example of this was when the Korean negative control 
group, which was predominantly female, had significantly lower arterial tortuosity than 
two other control groups. The system developed here was able to easily compare groups 
of females versus males to find out sex did not show any significant effect on arterial 
tortuosity. The database allowed iterative asking and answering of questions. 
Value of quantitative measurement 
 The quantitative measurement of tortuosity is useful for determining the 





screening of medical images. The experiments comparing the quantitative measure to 
human tortuosity scores had the people rank images according to arterial tortuosity. 
Ranking was used instead of having the person assign a numeric score because as the 
person sees new images they re-evaluate previous scores. A person is also unlikely to 
keep scores consistent when following a single patient over years. The quantitative 
tortuosity measure was partially automated in this study. The user only had to select the 
artery centerline ends. Work on automated centerline selection is underway. Artery 
characteristics such as diameter length and position are being used to automatically select 
the arteries. Automated tortuosity measurements could eventually be added to radiologic 
systems.  
Secondary use of image data 
 Clinical images provide a huge repository to study the effects of numerous 
vascular diseases on artery morphology. Up to now, studies on quantitative arterial 
tortuosity have imaged cases and controls under the same conditions. Clinical images are 
obtained on different machines at different resolutions. This research measured tortuosity 
of the same subjects at different resolutions to measure the effect of resolution on 
tortuosity in the hypertension experiment. Knowing the resolution effect allows 
comparison of clinical images taken at different resolutions. In the Korean hypertension 
experiment doubling the resolution from 0.4 x 0.4 x0.4 mm to 0.2 x 0.2 x 0.2 mm 
increased the tortuosity measurement 4.2±1.3% across five artery measurements. The 





15% increase in resolution of the LDS subjects versus the negative controls therefor 
resolution does not account for the increase in LDS arterial tortuosity. The use of clinical 
images will allow testing of arterial tortuosity of a variety of vascular diseases not 
commonly associated with increased visual tortuosity. 
Future work 
Arterial tortuosity in hypertension 
  The system of reuse of existing images makes possible more measurements of 
hypertensive populations that are needed to determine in hypertension correlates with 
increased arterial tortuosity. The hypertension experiment measured increased arterial 
tortuosity in one prospective Korean sample and did not detect a difference in the clinical 
Utah population. Future experiments could measure arterial tortuosity prospectively in 
additional hypertensive populations. Hypertensive patients could also be followed over 
time to determine if arterial tortuosity increases with progression of the disease or if 
tortuosity decreases with treatments lowering blood pressures. Repeated microvessel 
imaging of hypertensive patients before and after treatment showed some early indication 
of changes in microvessels [14]. It is not yet known if arteries lower tortuosity in 
response to treatment with anti-hypertensive medication. The tortuosity measurement 






Arterial tortuosity in LDS 
 High arterial tortuosity is one of the distinguishing characteristics between LDS 
and the more common Marfan syndrome (MFS) caused by the mutations in the FBN1 
gene; but clinically the two diseases’ tortuosities are only distinguished qualitatively [7, 
8]. Future research plans include measuring MFS patient tortuosity for comparison to 
LDS patients to determine if quantitative tortuosity screening can aid in identifying LDS 
patients misdiagnosed with MFS. LDS is caused by mutations in either the TGFBR1 or 
TGFBR2 genes [7]. The LDS patients in the intracranial aneurysm study here only had 
TGFBR2 mutations [9] but all LDS patients are known for increased tortuosity. The 
TGFBR1 and TGDFBR2 mutations show little phenotypic differences [15]. It is not 
known if one type has more tortuosity than the other. Quantitative tortuosity 
measurements between TGFBR1 and TGFBR2 mutation patients could determine if there 
is a difference. 
 Weakened arterial walls are a proposed cause of both arterial tortuosity and 
aneurysms [16]. Under this hypothesis arterial tortuosity would increase with age and 
correlate with aneurysm development. LDS is a genetic disease often diagnosed in 
pediatric patients that will be followed over time, once again showing the importance of 
distinguishing LDS from MFS patients that are not typically reimaged outside of the 
aortic arch area [9]. The high arterial tortuosity is seen in young patients but it is not 
known if arterial tortuosity increases over time. By obtaining images of the same patients 
taken over years quantitative arterial tortuosity measurements could be used to determine 





patients, quantitative tortuosity measurement could also be used to look for correlations 
between high or increasing arterial tortuosity and development of intracranial aneurysms. 
 MFS is not known to increase arterial tortuosity and it only raises the risk of aortic 
arch aneurysms. LDS increases tortuosity in head and neck arteries and raises aneurysm 
risk in the aortic arch and other arteries. The FBN1 and TGFBR1 and TGFBR2 proteins 
are all in the TGF-β signaling pathway but the difference in tortuosity and locations of 
aneurysms signals some difference in disease mechanism. 
 Quantitative measurement of LDS patient arterial tortuosity could potentially be 
used to monitor new treatments. It is possible treatment prevents normal increases in LDS 
patients or even decreases tortuosity, but these hypotheses need testing. The FDA 
approved TGFβ activity inhibiting antihypertensive drug Losartan is being tested in MFS 
patients and clinicians are using it to treat LDS patients [17]. MFS and LDS both show 
signs of TGF-β signaling pathway hyperactivity [17]. More is known about the MFS 
disease pathway than LDS disease. 
 MFS has a range for disease severity. MFS may be a dominant negative mutation 
in some of the most severe cases where the heterozygous FBN1 mutated gene product 
dimerizes with the healthy gene product[18]. The MFS genetic cause FBN1 is part and 
modulates the TGFβ signaling pathway [18]. The MFS mouse model homozygous mg∆ 
mice for MFS showed increased TGFβ in lung tissue [18]. These mice were successfully 






 LDS mutations affect TGFBR1 or TGFBR2 in the TGFβ signaling pathway. LDS 
is a mutation of TGFβ I or II receptor but results in increased TGFβ activity possibly due 
to a gain of function mutation or by triggering unproductive compensatory events since 
the receptor is less active [7, 19]. An LDS patient was known to have a duplication of the 
TGFBR1 gene adding further evidence of a gain of mutation function [10]. 
 The screening of images can be combined with medical record screening to 
identify undiagnosed LDS cases. Diagnoses of MFS or Ehlers-Danlos syndrome along 
with high arterial tortuosity are potential LDS cases. A diagnosis of an Arnold-Chiari 
malformation along with high arterial tortuosity is another flag for LDS. In LDS patients 
13.3% of 30 developed Arnold-Chiari malformations [8]. This study identified a patient 
with an Arnold-Chiari malformation and high-tortuosity (third highest left VA 
tortuosity). Arnold-Chiari malformation is rare, 1 in 1280 [20]. Because high tortuosity is 
also rare, the combination of two rare events could be an undiagnosed case of LDS. 
Future advances in automated arterial tortuosity measurement along with electronic 
medical record system screening could automate identification the rare LDS disease that 
clinicians will not be actively looking for due to its rarity. 
Quantitative phenotypes 
 Quantitation of phenotypes is necessary for epigenetic research. Due to rapidly 
dropping DNA sequencing costs there will be more genotype information on patients in 





be useful to measure the genotypic effects in medical images. Tortuosity is one example 
of measurement; there will be more in the future. 
 New technologies in automated DNA sequencing are making whole genome 
sequencing drop rapidly in time and price [12, 21]. There has been a 14,000-fold price 
decrease in DNA sequencing from 1999 to 2009 [22]. Exome sequencing that sequences 
only the protein coding part of the DNA, which is only around 1% of the human genome, 
is an even faster and less expensive alternative [21, 23]. There will soon be DNA 
sequence information available for individual patients usable for research and 
personalized medical treatment [12, 24]. 
 Genetic variation data are becoming more common but due to the lack of 
information on the function of genetic variation, genomics has had little impact on 
clinical medicine [22, 25]. Determining function from genotype is an open ended project 
[22]. Personalized medicine depends on an understanding of genetic and environmental 
factors [22]. The next challenge in genomics, as sequence data become an inexpensive 
commodity, is in linking genetic variation to physiology and disease phenotypes [24]. 
Medical imaging has the potential to measure phenotypes before they develop into 
clinical disease and has the potential to separate similar clinical phenotypes such as MFS 
from LDS and its subtypes. 
Contribution to the field of bioinformatics 
 Medical informatics is “the study, invention, and implementation of structures and 





communication, understanding, and management of medical information” [26]. The 
components of medical informatics are 1) signal processing, 2) database design, 3) 
decision making, 4) modeling and simulation, 5) optimizing interfaces between human 
and machine. This research involved signal processing of medical images and database 
design to allow comparison of subject tortuosity on many factors such as disease, age, sex 
and resolution of the image. By focusing on making secondary use of medical images this 
research will help enable reusing and combining data sets together to analyze tortuosity 
in arteries and diseases not studied before. This study also began a new line of research 
combining image processing, medical record analysis and genotype analysis to assist 
decision making. 
Summary 
 The DFE-COM centerline DFM curve tortuosity measurement system detected 
increased arterial tortuosity with hypertension and LDS validating the measurement 
method in these diseases. The tortuosity measure can be used to further study arterial 
tortuosity in hypertensive and LDS patients. Further study of hypertension could 
determine if tortuosity increases with progression of the disease. Quantitative tortuosity 
measurement is a potential method to distinguish LDS from related genetic syndromes. 
The quantitative measurement of phenotypes in medical images is a potential tool for 
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